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CHAPTER 1
IRON CHAPERONES FOR MITOCHONDRIAL IRON-SULFUR CLUSTER
BIOSYNTHESIS AND FERRITIN IRON STORAGE

1.1 Prelude:
The need for transition metals spans every living organism from viruses to human
beings. Cells traffic several transition metals to meet their dietary demand, but the
minerals that are absolutely required include the essential metals Fe, Zn, Cu, Mo, Co,
Mn, Cr, V and Ni [1]. Cells can also traffic additional metals, including Cd, Hg, Au and
Ag, however these are not required for cellular vitality and are effectively cleared out of
the cell to prevent toxicity [2]. The complement of metals required by cells is generally
influenced by their geochemical availability [3], and it has been estimated that
approximately a third to a fourth of all characterized proteins require metals for function
[2]. The unique physical and chemical properties of each metal are exploited during
their incorporation into metalloproteins, and the coordination chemistry specific to the
metal drives formation of the protein-metal complex. This permits metal bound proteins
to participate in several capacities that may be structural, catalytic or regulatory in
nature [4].
Although indispensible to sustain life, metals are also cytotoxic, owing to their
ability to initiate free radical reactions that can harm cellular components. Therefore
metal concentrations are tightly regulated by a battery of proteins that accomplish metal
homeostasis.

Proteins that serve in this capacity include integral membrane

transporters, metalloregulatory sensors, diffusible metallochaperone proteins and metal
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storage proteins. Studies of the amount of transition metals in E. coli have shown that
Zn & Fe are the most abundant with concentrations maintained at 0.1M, while Cu, Mn
and Se are maintained at 0.01M and V, Co & Ni are much lower in abundance [4].
Protein affinities for divalent metal ions follow the Irving Williams series, beginning with
the

weakest

binding

to

the

tightest,

in

the

following

order:

Mn2+<Fe2+<Co2+<Ni2+<Cu2+>Zn2+ [5]. In spite of the fact that higher affinity metals can
outcompete others for protein binding sites, in most cases proteins are loaded with the
correct metal. Loading is accomplished by several factors including:
A) Geometry: The metal may be inclined to bind the protein due to the availability of the
correct ligands, the right size of metal binding site and matching charges & solvation
energy that provide the metal bound protein with greater stability.
B) Function: In many cases proteins attain their biologically active conformation only
after binding the correct metal. Often, proteins improperly loaded with the wrong metal
exhibit an incorrect fold, exposing residues that are recognized by chaperone proteins
that bring about insertion of the correct metal or, they may be targeted for degradation.
C) Compartmentation of Proteins: The compartment/organelle that the protein folds
within also influences its metal binding as the complement of proteins involved in metal
insertion may differ between compartments. Once folded, the metal binding site may be
buried within the protein to prevent metal exchange with higher affinity metals.
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D) Protein delivery by metallochaperones: Some proteins are metallated via specific
protein-protein interactions directed by metallochaperone proteins that deliver the
specific metal to the protein [2, 4, 6].

1.1.1 The need for metallochaperone proteins:
Efficient and selective metal delivery is essential for proper metal homeostasis
and this chapter specifically highlights the role of metallochaperone proteins in this
process. Metallochaperones are diffusible proteins that bind metal ions and escort them
to partner proteins where they are delivered and transferred for incorporation as metal
cofactors into the apoprotein [4].

Chaperone proteins protect the metal from

participating in the generation of free radicals and hence protect the cell from potential
damage caused by free radicals. Metallochaperone proteins may operate in the cytosol
or in a subcellular compartment and they may even be found in circulation. As an
example, iron chaperones described so far include the human cytosolic PCBP family of
proteins, the mitochondrial iron chaperone protein frataxin (both of which have been
described in the review below), and the protein transferrin that ‘chaperones’ Fe3+ in the
blood [7]. Chaperones may activate proteins through direct metal insertion converting
the protein into its active holoform [8]. In addition, metallochaperones may interact with
metal import proteins from which they acquire their metal ions by specific ligand
exchange reactions rather than by scavenging metal released into the cytosol [2].
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It has been suggested that metal ions are always in the bound form inside the
cell. Metals are believed to be either bound to proteins or nucleic acids and other small
molecules such that the availability of free metal ions within the cell is far too low for
apoproteins to directly acquire them via passive diffusion. Their concentrations are also
reported to be ‘buffered’ keeping the amount of metal constant. For example, in case of
high affinity metals such as Cu & Zn, the pool of ‘free’ Cu has been reported to be about
one free ion per cell.

Zn efflux pumps are activated when the intracellular Zn

concentration reaches 0.5 fM, which corresponds to about one free Zn ion per cell.
Under such stringent conditions, cells employ metallochaperone proteins that can
incorporate metals using atypical coordination chemistry such that metals are bound
with a high affinity, yet can be delivered to recipients via specific protein-protein
interactions [4]. However, exchangeable cellular metal pools have also been described
for lower affinity metals like iron [6]. How these pools are maintained to achieve metal
homeostasis is currently under investigation.
The first chapter of my dissertation is a review that specifically outlines iron
homeostasis in health & disease.

This chapter provides in-depth insight into the

structure-function role of the iron metallochaperone frataxin, that operates in the
mitochondria & potentially serves as a source of iron for heme and iron-sulfur cluster
biogenesis, and the PCBP family of proteins, that operate in the cytosol and serve as
chaperones to Ferritin and other proteins. As my dissertation work is focused on the
Fe-S assembly pathway, this review provides the necessary background information
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regarding metal delivery for Fe-S cluster bioassembly and relates to the chapters that
follow. The bulk of this chapter been published in the following review: Subramanian,
P., Rodrigues, A.V., Ghimire-Rijal, S. and Stemmler, T.L. “Iron chaperones for
mitochondrial Fe-S cluster biosynthesis and ferritin iron storage” Curr. Opin. Chem.
Biol., 2011 15(2): 312-318.

1.2 Abstract:
Protein controlled iron homeostasis is essential for maintaining appropriate levels
and availability of metal within cells.

Recently, two iron chaperones have been

discovered that direct metal within two unique pathways: 1) mitochondrial iron-sulfur
(Fe-S) cluster assembly and 2) within the ferritin iron storage system.

Although

structural and functional details describing how these iron chaperones operate are
emerging, both share similar iron binding affinities and metal-ligand site structures that
enable them to bind and release Fe2+ to specific protein partners. Molecular details
related to iron binding and delivery by these chaperones will be explored within this
review.

1.3 Introduction:
Iron is essential for life and its unique chemical characteristics are often exploited
in nature to assist cells in performing inherently complex oxidation chemistry, promote
oxygen transport/storage and drive electron transfer pathways [9].

	
  

	
  

Iron is typically
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absorbed into the body through diet [10] and on average, humans absorb 1 to 2 mg of
iron from diet each day [11].

Although the amount of iron abstracted from the diet is

low, tight regulation of absorbed iron is critical, as humans have no physiologic pathway
to excrete metal. Once consumed, over 60% of the iron is incorporated into hemoglobin
through developing erythroid precursors and finally into mature red blood cells.

A

second and third possible fate for Fe includes being directed towards the iron storage
protein ferritin or being transferred throughout the body for incorporation into
metalloprotein iron cofactor sites. As a cofactor, Fe is often found associated within
iron-sulfur (Fe-S) clusters, found as mononuclear Fe-S, 2Fe-2S, 4Fe-4S and other
higher nuclearity clusters common to nature [12]. Given the body’s need to absorb and
maintain appropriate iron levels, Fe reuse and recycling from degraded sources is
another method the body uses to maintain iron homeostasis. A simple breakdown in
any of these pathways can lead to conditions that are detrimental to human health.
When maintained at balanced levels, iron is essential for cellular and organism
viability, however excess is toxic and deficiency leads to a variety of physiological and
developmental irregularities[11]. Disorders related to a breakdown in iron homeostasis
are among the most common human diseases. Diseases of iron overload are highly
prevalent, with the hepatological disorder hereditary hemochromatosis being one of the
most common [13]. Hemochromatosis patients absorb two to three times more iron
than normal dietary iron levels. Excess iron is often deposited in the liver and redox
chemistry performed by unregulated metal can kill the cell/organism. Neuronal iron
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accumulation is a phenotype of numerous neurodegenerative disorders (Parkinson’s
disease, Alzheimer’s disease, Friedreich’s ataxia, others).

In these disorders,

unregulated but redox active metal is pooled within specific regions of the brain
generating oxidative stress through iron produced reactive oxygen species (ROS)
formation [14].

ROS can damage membrane phospholipids and generate reactive

aldehydes that damage proteins, leading to accumulation of misfolded protein
aggregates. While examples of the toxic effects of iron overload are prevalent, iron
deficiency is an even larger human health issue affecting billions [15].

While iron

deficiency leads to decreased cognitive development in children [16], continual longterm deficiency leads to numerous other health related issues [11]. It is clear that
biological pathways controlling iron reactivity are essential, however it is equally clear
that pathways ensuring metal delivery occurs are equally important for maintaining cell
viability.
Many pathways that regulate cellular iron homeostasis are controlled at the
genetic and at the protein level [17, 18]. As outlined in the transferrin cycle, iron is
imported through endocytosis of Fe3+ loaded transferrin (Tf) interacting with the
transferrin receptor (Tf-R), in a tightly regulated feedback loop controlled at the genetic
and protein level (Figure 1.1). In eukaryotes, iron can be diverted to the mitochondria
where it can be utilized during heme production or during Fe-S cluster assembly
(pathway #1 in Figure 1.1).

During mitochondrial Fe-S cluster assembly, the ISC

machinery proteins work together to form clusters that can be loaded onto apo-
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mitochondrial proteins or pumped out of the mitochondria in some manner (labeled X) to
be used by the cytosolic Fe-S cluster assembly machinery (CIA). Cytosolic iron can
also be directed for storage into ferritin in an inert form for future use (pathway #2 in
Figure 1).

While there are obviously other fates for cellular iron, recently two iron

chaperones have been discovered that control iron delivery in the pathways highlighted
above. An overview of the structure and biophysical properties leading to iron binding
by these two chaperones is the basis of this review.

1.4 Fe-S cluster biosynthesis iron chaperones:
In eukaryotes, the mitochondrial ISC assembly is the major pathway for Fe-S
cluster production.

Key players in the yeast ISC machinery include the assembly

scaffold protein (either Isu1 or 2, for clarity we will refer to only Isu1), the cysteine
desulfurase (Nfs1) that provides sulfur to Isu1, the accessory protein (Isd11) that works
in complex with Nfs1, a ferredoxin (Yah1) working with a ferredoxin reductase (Arh1) to
provide electrons for the reaction, and the putative iron chaperone protein frataxin
(Yfh1) [19]. Protein orthologs are highly conserved and found in all eukaryotes, while in
prokaryotes most are found within the ISC pathway while variants of these proteins exist
within the sulfur mobilization (SUF) and the nitrogen fixation (NIF) assembly pathways
[20]. Isu1 is one of the most conserved proteins [21, 22], containing three conserved
cysteines critical for de novo Fe-S cluster assembly [23, 24]. Sulfur transfer between
Nfs1 and Isu1 occurs as a persulfide (-SSH) through a direct interaction between
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Figure 1.1: Major pathways for iron incorporation/utilization within a cell. Two
pathways for Fe2+ utilization highlighted within the review include: 1) Frataxin and its
role in mitochondrial Fe-S cluster assembly via the ISC-Machinery (* including the
cysteine desulfurase/Isd11 complex that provides sulfur); 2) PCBP and its role in
ferritin associated iron storage.
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partners [25]; insight into the nature of this interaction has come from a recent structural
characterization of bacterial orthologs [26]. In vivo, Yfh1 is essential for Fe-S cluster
maturation [27], and an interaction between Yfh1 and Isu1/Nfs1/Isd11 is critical for
cluster biosynthesis [28]. In vitro, frataxin was shown to deliver iron to the scaffold
protein to stimulate Fe-S cluster assembly [29]. Based on these and additional reports
(see review [19]), frataxin was shown to play a direct role in mitochondrial Fe-S cluster
assembly, possibly by serving as the iron chaperone[28, 30], deficiency of which has
direct consequences regarding cellular oxidative stress [31].
Insight into frataxin’s function has come from investigating the structure and iron
binding abilities of numerous orthologs [32]. Frataxin is a member of the a-b sandwich
motif family, with N- and C-terminal helices constructing one molecular plane and the
second constructed by at least five anti-parallel b-strands [33-38].

Key structural

features for the frataxin orthologs include highly conserved surface exposed acidic
residues lining the helix-1/strand-1 junction, a short predominately unstructured Nterminal region in eukaryotic orthologs only, and a C-terminal region in the human and
bacterial proteins that confer stability [39]. The iron binding ability of frataxin was first
identified in the yeast ortholog associated with iron induced aggregation stabilized by
low salt/high oxygen solution conditions [40].

Monomeric bacterial, yeast, fly and

human frataxin have since been shown to bind iron with micromolar affinity [29, 36, 4144], and in vivo mutations preventing Yfh1 aggregation show no Fe-S cluster
phenotypes under normal growth conditions [45], indicating while protein aggregation
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may be important under oxidative stress, monomeric frataxin is active during Fe-S
cluster assembly.

Experimental data verify conserved acidic residues on frataxin’s

helix-1/strand-1 junction are directly involved in iron binding [36, 41, 43]. Structural
studies confirm monomeric frataxin binds high spin Fe2+ in a symmetric 6-coordinate
ligand environment constructed of only oxygen and nitrogen ligands, in agreement with
the conserved acidic residue identified by NMR as iron ligands [43, 44, 46]. These data
suggest as a starting point for iron delivery, frataxin binds iron using carboxylate side
chain oxygens from conserved Asp and Glu residues from the helix-1/strand-1 iron
binding sites, most likely with assistance from water molecules. Binding in this manner
would predispose iron for delivery to Isu1 (Figure 2) since the exposed metal would be
positioned for delivery to the protein partner and the charged surface surrounding the
metal would be amenable for forming an interaction with a complementary charged
region of the protein partner.
Yfh1 undergoes an iron-stimulated interaction with Isu1/Nfs1 [28, 47, 48] in
agreement with frataxin interacting directly with members of the ISC assembly
machinery. In vivo mutational studies place frataxin’s acidic helix-1/strand-1 ridge, with
residues on the Yfh1 β-sheet surface, as interacting with Isu1 [47-51]. In vitro binding
interactions show frataxin/scaffold binding is iron dependent and occurs at nM binding
affinity [44, 52, 53]. Chemical shift mapping studies provide spectroscopic confirmation
that Isu1 interacts with Yfh1 on frataxin’s acidic helix-1/strand-1 ridge utilizing the
protein’s β-sheet surface, in close agreement with in vivo mutational analysis [53]. In
eukaryotic systems, activity assays for Fe-S cluster production confirm iron loaded
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frataxin stimulates in vitro Fe-S cluster assembly, possibly by delivering the Fe2+
required for cluster production [29, 44, 54].

Direct structural details of the

frataxin/scaffold interaction are however lacking. Two recent structural papers shed
light

on

the

potential

binding

interaction

between

these

protein

partners.

Crystallographic data on the Aquifex aeolicus IscU ortholog, with cluster bound, confirm
the three conserved Cys residues implicated in assembly form the active site of IscU
[55]. An even more exciting result comes from the structure of the bacterial cysteine
desulfurase (IscS) in complex with IscU [26]. This structure shows IscU binds to IscS
such that the IscU Cys active site is in close contact with the IscS Cys residue
implicated in forming the persulfide used for sulfur transfer. Binding of Isu1 to Nfs1 in
this manner would prevent frataxin from interacting in this region, assuming sulfur
delivery happens before iron delivery.

Irrespective of this assumption, mounting

evidence suggests all proteins in the ISC machinery form a complex that promotes the
formation of a stable macromolecular complex used to accomplish cluster assembly, so
the frataxin piece of this puzzle would need to fit in a unique location on Isu1. A likely
candidate for where Yfh1 could bind to Isu1 is on the scaffold protein’s C-terminal helix
(Figure 1.2) [53]. The charge distribution from the electrostatic potential surface of Isu1
in this region matches nicely to the Yfh1 b-sheet surface.

Conserved acidic/basic

residues on Isu1’s C-terminal helix could serve as the initial Fe2+ binding residues, metal
could then translocate to the scaffold’s active site [53]. Positional orientation of bacterial
frataxin on the IscS/U from small angle X-ray scattering studies [56] suggest that such
an orientation may be possible, although this orientation is likely to be altered between
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Figure 1.2: Molecular details of the 2 Fe2+ binding sites on Yfh1 (PDB #2GA5),
and the Cys rich active site on Isu1 (modeled structure) coupled with possible
Isu1 Fe2+ binding sites on the protein’s C-terminus. Ferrous iron (blue dots) shown
with arrow denoting Fe transfer events between the two proteins.
	
  

	
  

	
  

	
  

14	
  

the prokaryotic and eukaryotic orthologs since the accessory protein Isd11 found only in
eukaryotes is likely also positioned in this region. Following Fe delivery to Isu1 by Yfh1,
the binding energetics are reduced, frataxin dissociates from its partner and Isu1 is
primed for delivery of the second Fe atom required to make a 2Fe-2S cluster.
Recently it has been suggested frataxin may participate in Fe-S cluster
biosynthesis by regulating activity of the cysteine desulfurase. NMR mapping studies of
bacterial frataxin (CyaY) onto the bacterial IscS suggest residues lining frataxin’s bsheet ridge tangential to the C-terminus of helix 1, with helix-1 residues, participate in
IscS binding [57]. Mutagenesis and binding studies implicate a region on one IscS
monomer, in proximity to the persulfide site in the second molecule in the dimer, as the
CyaY binding surface on IscS [26]. Recent studies suggest CyaY acts as an irondependent inhibitor of cluster formation by negatively regulating IscS activity [57]. In
contrast, another recent report suggests human frataxin acts as an allosteric activator of
Nfs1 [58]. Regardless, binding of frataxin to the ISC machinery is important during
assembly and it will be interesting to see how this binding is finally correlated to iron
delivery and assembly.

1.5 Ferritin iron chaperones
Cellular pathways directing iron storage are essential for preventing iron toxicity
during overload and ensuring availability during deficiency. Storage is directed by the 4helix bundle protein ferritin [59]. Mammalian cytoplasmic ferritins exist as a 24 subunits
multimer of 2 ferritin subunit: H chain (21,000 kDa), which controls the ferroxidase
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chemistry coupled to iron storage, and the L chain (19,000 kDa). Apo-ferritin H and L
chains self-assemble to form a spherical protein shell that stores up to 4500 iron atoms
as ferroxyhydrite within the central cavity. Iron storage involves two key steps: iron
oxidation, leading to formation of a μ-oxo(hydroxo)-bridged di-Fe(III) intermediate, and
mineralization, depositing the intermediate as inert ferrihydrite mineral. To proceed,
iron must first be delivered to ferritin, and ferrous iron delivery occurs at a ferritin
oligomer hydrophilic threefold (iron entry) channel. H-chain surface exposed residues
H118 [60] and C130 [61], with threefold channel funnel-like forming residues Asp131
and Glu134 [62], are used during iron import.

Binding of an iron chaperone must

therefore proceed through direct contact with ferritin’s three-fold iron entry site (Figure
1.3).
Recently, the human poly (rC)-binding protein (PCBP) was shown to function as
a cytosolic iron chaperone that delivers Fe2+ to ferritin [63]. The RNA-binding PCBP
protein family was originally shown to be important in mRNA stabilization and
translational activation/silencing [64].

PCBPs have 3 KH (hnRNP K homology)

domains, with structures of the two N-terminal domains and the third domain of PCBP2
being characterized [65, 66]. Expression of human PCBP1 recovered an iron loading
deficiency for human ferritin expressed in yeast [63]. PCBP1 binds to ferritin in vivo and
in vitro facilitates iron loading.

PCBP1 binds 3 iron atoms at mM binding affinity

comparable to frataxin’s iron affinity [32]. Metal binding sites on PCBP are unknown,
however recent iron structural data indicate PCBP1/2 bind ferrous iron in a 6-coordinate
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Figure 1.3: Structural details of PCBP as a ferritin iron chaperone. Top Right:
PCBP2 total projected structure based on domains 1,2 (PDB #2JZX) and domain 3
(PDB #2P2R) structure linked together for visual clarity associated with 3 bound
iron atoms (blue dots). Top Left: structure of the human ferritin 24-mer (PDB
#3AJO) with iron loaded (blue dot) trimeric symmetry center. Bottom Left:
expansion of the ferritin trimeric interface with residues from three subunits involved
in Fe2+ loading (H118 and C130). In addition, residues (D131, E134) on the inner
side of the iron incorporation gate that support metal exchange are also given.
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oxygen/nitrogen ligand environment (author’s unpublished results). Although molecular
details of PCBP as an iron chaperone are still emerging, it is interesting to note that
thermodynamic and structural data regarding PCBP iron binding are so similar to that of
the Fe-S assembly iron chaperone.

1.6 Conclusions
Evidence that frataxin and PCBP are iron chaperones is compelling, although
clarification of their function at the genetic, molecular and atomic levels will be important
for understanding how they operate.

There are still many questions that remain

regarding the identity of other chaperones, how iron is loaded onto a chaperone and
what promotes chaperone metal specificity? A possible candidate for the first question
is the Glutaredoxins Grx3/ 4, members of the thioredoxin (Trx) fold family. Grx3/4 are
central for cellular iron trafficking and a strong dependence of iron binding for Grx3/4 on
core components in the ISC pathway indicate Grx3/4 bind iron as a Fe-S cluster [67].
The ability to form a bridging 2Fe-2S cluster with Fra1/2 for activation of Aft1 [68],
coupled with the direct dependence of Grx3/4 on iron loading into heme, Fe-S clusters,
into ribonucleotide reductase, etc. suggest iron activated by Grx3/4 may be utilized by
other dedicated assembly factors [67]. Frataxin and PCBP are most likely the start of a
soon to be recognized long list of iron chaperones.
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CHAPTER 2
IRON BINDING AND INITIAL METAL LOADING SITE ON THE ISU SCAFFOLD
PROTEINS

2.1 Prelude
The iron-sulfur (Fe-S) cluster scaffold protein, ISU drives the chemistry
associated with mitochondrial Fe-S cluster assembly. This process is accomplished by
an interaction of ISU with several protein partners, stimulating the process of ferrous
iron delivery and sulfide delivery in the process. One of our early goals was to take an
individual molecular approach to understand how cluster assembly is accomplished.
Given the importance of ISU in the assembly process, we would like to deconstruct the
substrate delivery events with the cluster assembly events in a step-wise manner, with
the hope of determining mechanistic details that lead to the assembly process.
Therefore, we began by looking at the iron loading events for how ISU is initially
exposed to substrate. To accomplish this, we did a comprehensive characterization of
ISU iron loading events.
The work described below, which is directed to accomplish this aim, was
performed on four ISU orthologs:

human, fly, yeast and bacteria.

This work was

initiated by previous graduate students in the Stemmler laboratory: Dr. Jeremy Cook
and Dr. Swati Rawat, in collaboration with the Cowan laboratory (Ohio State) and the
Lindahl laboratory (Texas A&M). Saccharomyces cerevisiae Isu1 (or YIsu1) used in
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these studies was a variant that contained a D37A mutant that locked the synthesized
cluster in place while the complementary experiments were performed on the wild type
ISU orthologs. My goal was therefore to complete the complementary experiments on
the wild type (WT) Sc Isu1 protein, to set the basis for comparison of orthologs under
similar conditions.

I have optimized expression & purification of the WT Sc Isu1

ortholog, and characterized the protein in detail in this and the subsequent chapter.

2.2 Abstract
Fe-S clusters are utilized in nearly every biochemical pathway. The chemistry of
iron is modulated by incorporation of metal into Fe-S clusters, protein bound cofactors
that drive biochemical pathways ranging from steroid biosynthesis to energy production.
In eukaryotes, clusters are assembled by the Isu scaffold protein. The iron-sulfur (Fe-S)
scaffold protein ISU occurs ubiquitously among all organisms. The ISU proteins have
three conserved cysteine residues in the active site that coordinate iron and sulfur
during the synthesis of a cluster. The source of sulfur for cluster assembly is the protein
cysteine desulfurase that catalyzes the conversion of cysteine to alanine forming an
active persulfide that appears to be transferred directly to ISU’s active site. Frataxin, a
potential mitochondrial iron chaperone protein, has been identified to provide the
putative source of iron, however, the region of binding and/or delivery of iron onto ISU
remains unknown.

	
  

In this study the ISU iron binding properties of four orthologs
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(human, fly, yeast and bacteria) have been characterized and compared to identify
unifying factors for iron utilization. Isothermal titration calorimetry studies show ISU can
bind iron alone with a nano- to micromolar binding affinity.

X-ray absorption

spectroscopy results show that the Fe(ll)-ISU complex is composed of a ligand
environment that is completely oxygen/nitrogen based in all orthologs, indicating Isu
binds iron at a site distinct from its cysteine rich active site. Mössbauer spectroscopy
confirmed the iron-oxygen/nitrogen ligand environment at this metal “acceptance” site.
In addition to identifying a unique iron-binding site on ISU, a model for Fe delivery to ISU
has been proposed.

2.3 Introduction
In the pre-biotic milieu of ancient earth, Fe-S clusters were most likely among the
first chemical compounds to perform the chemistry essential to life processes [1]. Fe-S
cofactors are used ubiquitously throughout biology to perform basic catalytic, electron
transfer, and regulatory roles [2, 3]. Three dedicated pathways and upwards of at least
20 different proteins have been identified for the formation of these ancient cofactors [4].
The major pathway within the mitochondria responsible for general Fe-S cluster
production is the iron-sulfur cluster (ISC) biosynthetic pathway [4]. Assembly of Fe-S
clusters within the ISC pathway requires a highly conserved scaffold protein on which
the cofactors are assembled (termed ISU or IscU in eukaryotes and prokaryotes,
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respectively) [5-8]. Sulfide is provided by a cysteine desulfurase, NifS (along with an
accessory protein, Isd11 in eukaryotes) [4, 6, 9]. Frataxin, a chaperone protein, is
believed to be the putative iron donor [6, 10-14].

Although genetics studies have

identified many of the players involved during assembly, many biochemical details of the
pathway are still unclear. ISU proteins contain three highly conserved cysteine residues
and a semiconserved histidine residue; in the active site [15, 16]. This finding was
recently validated in prokaryotes by the crystal structure of IscU with a 2Fe-2S cluster
bound [17]. However, the enzymatic mechanism for Fe-S cluster production remains
unknown. In this report, we seek to characterize four highly homologous ISU orthologs
(Homo sapiens, Drosophila melanogaster, Saccharomyces cerevisiae and Thermatoga
maritima) in the hope of clarifying the initial steps of Fe binding to ISU proteins. Isu
proteins studied in this report exhibit 80% (Dm), 73% (Sc), and 28% (Tm) sequence
identity to the human homolog (Figure 2.1).

We present both structural and

biochemical data that suggest the presence of a metal binding site on the protein
independent of the active site in each of the ISU proteins.
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2.4 Materials and Methods:
2.4.1 Protein Expression and Purification
S. cerevisiae Isu1 containing a D37A mutation was subcloned into a pET21b
expression vector (Novagen) with a C-terminal His tag and the sequence was confirmed
by DNA sequencing. Plasmid was transfected into BL21(DE3) CodonPlus cells and
grown by auto induction [18] at 25°C for ca. 24 hrs. before harvesting by centrifugation
(5000 rpm, 45 min). All protein isolation steps were all performed at 4°C. Cells were resuspended in 50 mM NaPO4 (pH 7.5), 300 mM NaCl, 20 mM Imidazole, and 5 mM β-Me
(5 mL/g cells) in the presence of Complete EDTA free protease inhibitor cocktail
(Roche). Cells were lysed during two passes through a French press cell followed by 2
rounds of sonication (50% power), and spun at high speed (21000 rpm) for 1 hour. The
crude soluble fraction was filtered (0.20 μm) and loaded onto a HisPrep FF Ni-column
(Pharmacia) using an Imidazole gradient (20-500 mM, protein elutes ~ 120 mM). Active
fractions were pooled and concentrated to ca. 1 mL using 3 kDa cutoff centricons
(Millipore) and run over a Sephadex 75 size exclusion column (Pharmacia) equilibrated
with 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me. The protein eluted as a
dimer at ≥ 95% purity (typical yields were 1 mg/L). D. melanogaster mature wild type
ISU was subcloned into a pET151D-TOPO expression vector (Invitrogen) with cleavable
His-tag and then sequenced. Plasmid was transfected into BL21(DE3) CodonPlus cells
and grown by auto induction [18] at 25°C for ca. 24 hrs. before harvesting by
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centrifugation. Protein was isolated as described above with typical yields of 27 mg/L.
The plasmid containing the Sc Isu1 WT gene was transformed into BL21 codon plus RIL
cells (Stratagene) for protein expression. Cells were grown at 370C in Luria-Bertani
broth containing Ampicillin (0.1 μg/ μl) and Chloramphenicol (0.05 μg/ μl) with shaking
speed set at 250rpm. At OD600 of 0.6 cells were induced for protein expression by the
addition of 0.8mM IPTG.

Post induction expression conditions were found to be

optimum at a temperature of 370C, over a period of 3 hrs. following which the cells were
harvested by centrifugation and stored at -800C until lysis. Protein purification followed
methods similar to those described above. Wild type Sc Isu1 eluted as a dimer. Pure
fractions were pooled and protein concentration was determined using IR Spectrometry
(EMD Millipore Direct Detect).

Purification yielded about 2.5 mg/ml of ≥ 95% pure

protein from ~ 50gm cells. Purified samples of the H. sapien and T. maritima orthologs
were generously provided by the Cowan lab (Evans Laboratory of Chemistry, Ohio State
University), expression and isolation protocols are described elsewhere [10, 12, 19].
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Figure 2.1. Sequence alignment of ISU proteins. Mature protein sequences from H.
sapiens, D. melanogaster, S. cerevisiae and T. maritima were aligned using Kalign v2
software [20]. The conserved 3-Cysteine active site consists of C71, C98 and C159
according to the consensus ruler.
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2.4.2 Isothermal Titration Calorimetry experiments & analysis:
Isothermal titration calorimetry (ITC) measurements were performed to measure
the binding affinity and maximum stoichiometries of ferrous iron to each ISU protein.
Experiments were performed at 30 °C on a VP-ITC titration microcalorimeter (Micro Cal
Inc.). A solution containing 30 μM ISU (human, yeast and Thermatoga) was thoroughly
degassed and loaded into the adiabatic cell and 500 μM buffered anaerobic ferrous iron
solution was loaded into the syringe.

The Fe into Dm Isu ITC experiment was

conducted by titrating a 2.1 mM ferrous iron solution into 90 µM DIsu solution in small
increments. An initial 2 μL injection was followed by 29 additional injections of 10 μL
titrant allowing 10 min between each injection to allow for complete equilibration with
constant stirring (500 rpm). Both sample and titrant were in matched 20 mM HEPES
(pH 7.5), 150 mM NaCl and 5mM β-Me buffer. Data was collected in duplicate and
protein samples were extensively degassed and buffers were purged with Ar (g) to help
stabilize the iron in the ferrous state. Data was fit and analyzed using the Origin 5.0
software package supplied by Micro Cal (GE life sciences), which uses a non-linear
least squares curve fitting algorithm, to determine the stoichiometric ratio, dissociation
constant and change in enthalpy of the reaction.
Experimental parameters for the WT Sc Isu1 to Fe (ll) titration was similar as
described above. A 1 mM solution of Fe (ll) was titrated into 50 µM solution of WT Sc
Isu1 protein. Both solutions were prepared in the same buffer, which contained 20 mM,
HEPES (pH: 7.5), 150 mM NaCl, 5 mM β-ME. The parameters of the ITC experiment
are the same as described above.

	
  

	
  

	
  

35	
  

2.4.3 XAS Sample Preparation and Analysis
X-ray absorption spectroscopy (XAS) was used to study the electronic properties
and ligand coordination geometry of iron bound to different ISU orthologs. All samples
were prepared anaerobically within a glove box (PlasLabs) using protein and iron
solutions that were initially degassed on a Schlenk line and stored under an Ar(g)
atmosphere. XAS samples were prepared at ~0.5 mM final protein concentrations in 20
mM HEPES (pH 7.0), 150 mM NaCl and 5 mM β-Me buffer. WT Sc Isu1 samples were
prepared as described above in buffer containing 20 mM HEPES (pH: 7.5), 250 mM
NaBr, 5 mM β-Me. Samples were diluted with 30% glycerol as a glassing agent and
loaded into Lucite cells wrapped with Kapton tape, flash frozen in liquid nitrogen,
removed from the glove box and stored in liquid nitrogen until data collection.
XAS data were collected at the Stanford Synchrotron Radiation Laboratory
(SSRL), on beamlines 7-3 and 9-3, and at the National Synchrotron Light Source
(NSLS), on beamline X3b. Beamlines were equipped with harmonic rejection mirrors
and either Si(220) double crystal monochromators or a Si(111) single crystal
monochromator, at SSRL and NSLS, respectively. Samples were maintained at 10 K
using an Oxford Instruments continuous-flow liquid helium cryostats at SSRL and at ca.
24 K using a He Displex Cryostat at NSLS. Protein fluorescence excitation spectra
were collected using 30-element Ge solid-state array detectors at SSRL and a 13element Ge solid-state detector at NSLS. XAS spectra were measured using 5 eV
steps in the pre-edge regions (6900-7094), 0.25 eV steps in the edge regions (7095-

	
  

	
  

	
  

36	
  

7135 eV) and 0.05 Å-1 increments in the extended X-ray absorption fine structure
(EXAFS) region (to k = 13.5 Å-1), integrating from 1 to 20 s in a k3 weighted manner for
a total scan length of approximately 40 minutes. X-ray energies were calibrated by
collecting an iron foil absorption spectrum simultaneously with collection of the protein
and model data. The first inflection point for the Fe foil edge was assigned at 7111.3
eV. Fluorescence channels for each scan was examined for spectral anomalies prior to
averaging and spectra were closely monitored for photoreduction.
SSRL protein data represent the average of 5 to 6 scans, while NSLS protein
data represent the average of 8 to 9 scans.

XAS data were processed using the

Macintosh OS X version of the EXAFSPAK program suite integrated with the Feff v7.2
software for theoretical model generation [21]. XAS data reduction utilized a Gaussian
function in the pre-edge region and a three-region cubic spline in the x-ray absorption
fine structure (EXAFS) region. EXAFS data were converted to k-space using an E0
value of 7130 eV. The k3 weighted EXAFS was truncated at 1.0 and 12.85 Å-1 for
filtering purposes and Fourier transformed. The final fitting results presented are from
analysis of the raw unfiltered data.
EXAFS data fitting analysis performed on both Fourier filtered and raw/unfiltered
data gave equivalent structural results. Model and protein EXAFS data were fit using
both single and multiple scattering amplitude and phase functions calculated using Feff
v7.2. Single scattering Feff v7.2 models were calculated for carbon, oxygen, sulfur and
iron coordination to simulate possible iron-ligand environments in our systems. Fits to
the crystallographically characterized model compounds were used to calibrate the
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scale factor and ΔE0 values which we used in our protein fits. A scale factor of 0.95
and a threshold shift (ΔE0) -11.5 eV were used during our protein data analysis. The
scale factor and E0 were not allowed to vary as they were calibrated from the Fe(II)
model compounds matching the oxidation state of the ferrous iron we found in our
protein samples. When simulating empirical data, metal-ligand coordination numbers
were fixed at half-integer values while only the absorber-scatterer bond length (R) and
Debye-Waller factor (σ2) were allowed to freely vary. The criteria for judging the best fit
simulation, and for adding ligand environments to the fit, included: (A) the lowest mean
square deviation between data and fit (F’), a value corrected for number of degrees of
freedom in the fit, (B) individual shell bond distances must be outside the spectral
resolution (> 0.13 Å), and finally (C) all Debye-Waller factors in the ligand system must
have values less than 0.006 s2.

2.4.4 Mössbauer Spectroscopy Sample Preparation and Data Analysis
Mössbauer samples were prepared anaerobically in a glovebox (PlasLabs), and
all proteins and solutions were first extensively degassed on a schlenk line. Ferric

57

Fe

was dissolved in a mixture of HCl/HNO3 and reduced to the ferrous form using sodium
hydrosulfite in a basic solution under anaerobic conditions. Iron oxidation state was
confirmed using the Fe(II) specific chromophore bipyridine.

The reduced iron was

combined with ISU protein samples at a 1:1 stoichiometry and allowed to equilibrate for
10 min at room temperature prior to loading into the sample cells. Samples were frozen
in the glovebox using an aluminum block bathed in liquid nitrogen. Mössbauer spectra
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were also collected at Texas A&M University using a model MS4 WRC spectrometer
(WEB Research, Edina, MN) with a 4.5 to 300 K closed-cycle helium refrigerated
system and a W106 temperature controller. Data was analyzed using the WMOSS
software package (WEB Research, Edina, MN). Isomer shifts are quoted relative to Fe
metal at 298 K.

Spectra were collected for 24 h at 4.5 K and 100 K with little

distinguishable difference in spectral features.

2.5 Results
2.5.1 ISU Proteins Directly Bind Iron
In order for the protein-assisted assembly of Fe-S clusters to occur within the ISC
pathway, ISU proteins must be capable of binding iron. Using ITC, we observed ISU
proteins have a direct interaction with ferrous iron. It has been previously shown the Tm
and Hs proteins are capable of binding ferrous iron at micromolar binding affinities [12,
15]. We observe similar results in the two additional species; Dm and Sc (D37A).
Measurements of both Dm and Sc ISU were performed anaerobically in buffered
solutions that helped increase protein stability (20 mM HEPES (pH 7.5), 150 mM NaCl
and 5 mM β-Me). Addition of iron resulted in a strong single exothermic reaction shown
in Figure 2.2 A, C for both Dm and Sc ISU. Plots of the integrated heat released vs.
molar ratio are shown in Figure 2.2 B and D for Dm and Sc ISU, respectively. Data
were best fit in both cases using a 2 binding-site model using the Origin 5.0 software.
Dm Isu binds approximately 1.21± 0.25 Fe(II) atoms with an apparent KD1 of 475 ± 166
nM and 1.40 ± 0.07 Fe(II) atoms with a KD2 of 64.5 ± 17 nM. Sc Isu1 (D37A) binds ca.
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Figure 2.2. Fe(ll) binding to ISU proteins by ITC. Raw isothermal titration calorimetry
and binding isotherm data for ferrous iron binding to ISU proteins. Raw heat released
data for Dm ISU (A) Sc Isu1 D37A (C) and Sc Isu1 WT (E) binding to ferrous iron,
simulated fits to the binding isotherm data for Dm Isu (B), Sc Isu1 D37A (D) and Sc Isu1
WT (F). Data were collected anaerobically at 30°C in 20 mM HEPES (pH 7.5) and 150
mM NaCl and 5mM β-Me. Spacing between injections was 10 minutes. Syringe stirring
speed was kept at 500 rpm.
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Table 2.1. Fe (II) binding affinities of ISU proteins. ITC fitting parameters for ISU
proteins binding ferrous iron. Averaged values for stoichiometry (N1 and N2) and
dissociation constants (KD1 and KD2) are provided with error bars.

Ortholog

N1

KD1

N2

KD2

H.sapien

1.0‡

2.0 ± 0.2 uM

---

---

D.melanogaster

1.21 ± 0.25

475 ± 166 nM

1.40 ± 0.07

64.5 ± 17 nM

S.cerevisiae
(D37A)

1.19 ± 0.66

234 ± 35 nM

0.97 ± .31

6 ± 4 nM

T.maritima

1.0§

2.7uM

---

---

S.cerevisiae
(WT)

1.61 ± 0.16

0.98 ± 0.75
uM

0.6 ± 0.16

18 ± 7.24 nm

‡ [16]
§ [15]
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1.19 ± 0.66 atoms Fe(II) with a KD1 of 234 ± 35 nM and 0.97 ± 0.31 atoms Fe(II) with a
slightly tighter KD2 of 6 ± 4 nM. These binding affinities are slightly tighter compared to
previously published data for Hs and Tm ISU, of which both bound Fe(II) in the μM
range (Table 2.1); however, the Hs and Tm data were collected under different buffer
conditions [12, 15, 16]. The WT Sc Isu1 sample, as the D37A Sc Isu1 variant bound ca.
1.61 ± 0.16 atoms Fe (II) with a KD1 of 0.98 ± 0.75 μM and 0.6 ± 0.16 atoms Fe (II) with
a tighter KD2 of 18 ± 7.24 nM shown in Figure 2.2 E and F.

2.5.2 Iron Coordination Geometry of ISU Proteins
XAS studies were used to probe the structural details of initial iron loading onto
ISU type proteins. Full XAS data sets were collected on multiple independent samples
of Hs, Dm, Sc and Tm ISU proteins with one iron bound. Samples were prepared
anaerobically and loaded into each sample cell while the protein was inside a glove box.
XANES analysis revealed iron was predominantly in the Fe(II) state as compared to
ferrous iron controls, based on the analysis of the first inflection point of the edge
feature for each spectrum. Raw EXAFS data for all 4 ISU samples show a predominant
single frequency pattern centered at ca. 5-6 Å-1 and this is suggestive of a nearestneighbor coordination environment constructed of only O/N based ligands (Figure 2.3
A, C, E, G black lines). An apparent ‘camel back’ feature is observed for the Hs and
Tm samples (Figure 2.3 A and G, respectively) suggesting the presence of a Histidine
ligand, but this feature is not present in the other samples. Fourier transforms of the
data for Hs, Dm, Sc and Tm ISU proteins (Figure 2.3 B, D, F, H, black lines,
respectively) indicate a predominant single nearest neighbor ligand environment feature

	
  

	
  

	
  

42	
  

Figure 2.3. EXAFS and Fourier transforms of iron loaded ISU XAS data.
EXAFSspectra in black (A,C,E,G) and FT (B,D,F,H) data, and best fit simulations shown
in green of H. sapiens (A,B) D. melanogaster (C,D), S. cerevisiae (E,F) and T. maritima
(G,H) ISU proteins bound to 1 Fe atom.
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Table 2.2. Summary of EXAFS fitting results for Fe bound ISU proteins. Data fit
over a k range of 1 to 12.5 Å-1 using EXAFSPAK and feff7 theoretical models.

Fe-Nearest Neighbor
Ligands

a

Fe•••Long Range Ligandsa

Sample

Atomb

R(Å)c

C.N.d

σ2e

Atomb

H.sapien

O/N

2.01

1.5

2.02

O/N

2.14

4.0

1.28

D.melanogaster

S.cerevisiae

T.maritima

O/N

1.99

3.0

3.78

O/N

2.15

2.0

2.94

O/N

2.01

1.0

1.91

O/N

2.14

4.5

3.25

O/N

2.13

6.0

4.30

a

R(Å)c C.N.d

σ2e

F’ f

C

3.13

3.0

5.83

0.45

C

3.52

1.0

1.0

C

4.13

6.5

5.95

C

3.13

1.5

3.01

0.32

C

3.01

1.5

1.14

0.99

C

3.10

3

1.56

0.99

C

3.27

4.5

1.20

C

3.49

4.5

1.66

C

3.71

3.5

3.9

Data were fit over a k range of 1 to 12.5 Å-1.
b
Independent metal-ligand scattering environment
c
Scattering atoms: O (oxygen), N (nitrogen), S (sulfur) and C (carbon),
d
Average metal-ligand bond length from two independent samples
e
Average metal-ligand coordination number from two independent samples
f
Average Debye-Waller factor in Å2 x 103 from two independent sample
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centered around a phase-shifted bond length (R + Δ) of ca. 1.8 Å, with minimal
scattering from long distance ligands. Hs, Dm, and Sc data were best fit using 2 O/N
shell nearest neighbor simulations (Figure 2.3 A, C, E, green lines) while Tm samples
could only be fit using a single O/N shell (Figure 2.3 F). Long-range scattering could
only be fit with carbon scattering, attempts with fits using sulfur or iron atoms decreased
the quality of the fit. The best-fit simulations are summarized in Table 2.2. All samples
show partially disordered ligand environments with total coordination around 6, as would
be expected for an Fe(II) with octahedral symmetry. Interestingly, there is no evidence
for sulfur ligation in any of the samples. All orthologs studied appear to have similar but
not identical metal binding characteristics using O/N based ligands.
The x-ray absorption near edge (XANES) plot for WT Sc Isu1 is plotted with two
octahedral iron model complexes, ferrous and ferric sulfate (Figure 2.4).

When

compared to the models, pre-edge and edge features of the WT protein are similar to
that of an octahedral oxygen/ nitrogen containing environment. Edge energy at half
height of the rising edge for the WT sample is 7120 eV, and that for ferrous sulfate
control is 7119.5 eV, indicating a ferrous iron-containing complex.

These results

confirm the presence of an octahedral Fe (ll) complex bound to WT Sc Isu1.
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Figure 2.4: XANES spectrum of Fe (ll) bound to WT Sc Isu1. Spectrum for WT Sc
Isu1 shown in black solid line compared with two octahedral oxygen/nitrogen model
complexes: Ferrous sulfate (-x-) and ferric sulfate (--). Spectrum was collected at NSLS
X3B in buffer containing 20 mM HEPES (pH: 7.5), 250 mM NaBr, 5 mM β-Me. Two
equivalents of Fe(ll) was added to protein. Samples were prepared after overnight
incubation of protein & reagents in an anaerobic glove box.
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2.5.3 Metal Site Electronic Structure by Mössbauer Spectroscopy
Mössbauer spectroscopy was utilized as an alternative technique to probe the
metal site electronic structure of ferrous iron bound to ISU proteins.

The 4.5 K

Mössbauer spectra of each ISU protein anaerobically loaded with ferrous iron are
shown in Figure 2.5 and each was consistent with high spin ferrous iron constrained
within an octahedral ligand environment.

A single major quadrupole doublet was

observed for all samples, with δ values of 1.24, 1.20, and 1.27 mm/s for Hs, Dm and
Tm, respectively, and corresponding ΔEQ values of 2.35,1.94 and 2.76 mm/s (Table
2.3).

2.6 Discussion
The ISU family of proteins is essential for cellular Fe-S cluster assembly.
This family is highly conserved in their amino acid sequence, indicating a common and
ancient evolution. In this report, we characterize the structural and electronic properties
of ferrous iron bound to four members of the ISU family of proteins. Although ISU has
been shown at both a genetic and biochemical level to be the scaffold upon which Fe-S
cluster biosynthesis is orchestrated [5, 7, 15], the mechanistic details of Fe-S cluster
assembly still remain elusive and have been the subject of intense research efforts by
many research groups. Although cluster formation is chemically a simple task, it is still
unclear how these events occur in a strictly controlled protein environment. Both the
sulfide and iron donors have been identified which promote transfer of these substrates
to the scaffold protein however the subsequent cluster formation is difficult to observe
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Figure 2.5. Mössbauer spectra of ISU proteins. Top to bottom: Human Isu 4.5K
700G parallel field, Human Isu 100K 700G parallel field, Drosophila Isu 4.5K 400G
parallel field, Thermatoga Isu 4.5K 400G applied field. All samples have been collected
~24h for about 3-4 M counts of radiation.
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Table 2.3. Analysis of Mössbauer parameters for Fe(ll) bound ISU proteins.

Sample

δ (mm/sec)

ΔEQ (mm/sec)

Lw (mm/sec)

H.sapien

1.26

2.60

0.768

D.melanogaster

1.24

2.83

0.801

S.cerevesiae

NA

NA

NA

T.maritima

1.26

2.61

0.742

Aq Fe (II)

1.35

3.06

δ – Isomer shift
ΔEQ – Electric quadrupole
Lw – Line width at full width half maximum of signal
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directly at a molecular level.

It has been shown structurally that the product of cluster

formation is bound at the 3-Cys site and these 3 Cys residues are implicated as being
active site residues [17]. ISU proteins have previously been shown to bind iron, but
biophysical analysis of the metal center has always been after an intact cluster has
been formed [15, 16].

To help further elucidate the mechanistic details of cluster

formation by the ISU proteins, we characterized iron binding of ISU proteins across a
variety of species. A comparison of iron binding to ISU proteins by ITC shows these
proteins are able to bind ferrous iron with low nanomolar and sub-micromolar affinities.
These binding affinities are consistent with the copper chaperones have been studied to
date [23].
Frataxin, the proposed iron donor within the Fe-S assembly pathway has been
extensively studied using the human, fly, yeast and bacterial systems. To date, all
frataxin homologs studied have been observed to bind iron with binding affinities also in
the low micromolar range [13, 24-26]. Binding affinities for iron by the ISU proteins that
are tighter than the chaperones themselves suggests metal transfer is energetically
favorable. The process is most likely however much more complicated than simple
inter-residue transfer, with multiple proteins and conformational changes ultimately
leading to cluster formation. The KD values reported by the Cowan group for Hs (KD=
2.0 μM) and Tm (KD= 2.7μM) ISU proteins are lower than those reported here for Dm
(KD1= 475 nM, KD2= 64.5 nM) and Sc (KD1= 234 nM, KD2= 6 nM), but this may be
attributable to the fact that different solution conditions were tested during the
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experiments. It is clear that the different ISU proteins are capable of directly binding
ferrous iron and this certainly has direct mechanistic implications regarding the protein’s
enzymatic function.

We therefore probed the metal binding characteristic of these

family members to further explore how clusters are assembled.
XAS and Mössbauer studies of ferrous iron bound to ISU proteins are consistent
with a metal-ligand coordination environments constructed of only oxygen and nitrogen
based ligands. XANES analysis of the iron edge for each ISU ortholog is consistent
with iron being stable in the ferrous state based on the first inflection point of the edge
and the primary energy feature of the 1s→3d transitions.

In addition, the 1s→3d

transitions areas and energies are consistent with the ferrous iron being stable in the
high-spin state. A quadrupole doublet observed in each Fe-ISU sample by Mössbauer
spectroscopy, with δ values at ca. 1.25 mm/s and ΔEQ ~2 mm/s, also supports the
presence of high spin ferrous iron. Both Mössbauer and EXAFS analysis indicate the
metal is coordinated to only O/N based ligands, these coordination environments differ
slightly between species. Best fit nearest neighbor environments for Hs ISU yield two
O/N shells with coordination numbers of 1.5 and 4 at distances of 2.01 and 2.15 Å,
respectively. Long-range ligand interactions at distances of 3.13, 3.52 and 4.13 Å are
most likely due to carbon atoms.

Dm Isu was also best-fit using two O/N ligand

environment with 3 O/N atoms at 1.99 Å and 2 O/N atoms at 2.14 Å. Long-range
interactions were also best fit with a carbon shell at 3.13Å. Similarly, Sc Isu1 was best
fit with two shells, the first composed of 1 O/N at 2.01 Å and the second composed of
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4.5 O/N at a distance of 2.14 Å. The long-range interaction at 3.01 Å was best fit with
carbon. Iron bound Tm IscU show a slightly different coordination geometry with only a
single O/N shell composed of 6 ligands at 2.13 Å, long-range carbon scattering was
best fit at 3.27, 3.49 and 3.71 Å.
Simulations to the different Mössbauer data qualitatively support these XAS
results. The ISU proteins from different sources have somewhat different isomer shift
and quadrupole splitting values, which suggests that the ligands are not precisely the
same in each. The isomer shift arises from differences in s-electron densities between
source and absorber nuclei and is sensitive to oxidation and spin state.

Here we

observe relatively high values (δ = 1.20-1.27) due to shielding of the outer s-electron
charge density by the inner 3d electron charge density indicating a metal center in the
S=2 high spin ferrous state. Additionally this shielding leads to the high quadropole
splittings of around 2-3 mm s-1. Although line widths are not extraordinarily large it is
possible they may indicate multiple spectral features, and therefore multiple species or
binding sites. Interestingly, the δ and ΔEQ for the different ISU proteins are not exactly
the same. This suggests some variation in coordinating ligands, with Tm having more
oxygen and Dm having the most nitrogen with Hs and Sc in between.
In summary, these data report clear evidence that the ISU proteins have an iron
binding site that is distinct from the Cys rich active site.

In particular, these data

indicate: 1) ISU orthologs are able to bind iron with high affinity and 2) ferrous iron is
bound initially via O/N based ligands. In this report, we focused solely on the initial
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process of iron binding to the ISU orthologs to gain insight into the Fe-S cluster
assembly pathway. It was originally assumed that both iron and sulfur addition to ISU
scaffold proteins occurred at the 3 Cys active site. Our data indicate ISU initially bind
iron in a step prior to cluster assembly at a distinctly separate site composed entirely of
non-cysteine ligands. The techniques used in this study do not provide any information
as to the identification of the residues that make up this initial metal binding site, nor
how the metal is transferred from the iron binding site to the active site. Insight into the
conserved sequences may provide further clarification into how these proteins bind iron.
Acidic residues are highly conserved in approximately 11 positions (9 of which are
completely conserved in our alignment) and 3 partially conserved His residues. We
therefore plan to target each of these residues in the future to provide better clarification
into which are at the Fe binding site.
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CHAPTER 3
IDENTIFICATION OF A PUTATIVE IRON BINDING SITE ON THE C-TERMINUS OF
YEAST IRON-SULFUR SCAFFOLD PROTEIN ISU &
IMPLICATIONS FOR IRON DELIVERY BY FRATAXIN

3.1 Prelude
This chapter describes my work directed at the identification and characterization
of the ISU Fe binding site described in Chapter 2. X-ray absorption spectroscopy (XAS)
studies showed that this site was found to be composed entirely of oxygen/nitrogen
based ligands, distinct from the protein’s thiol rich active site. The goal of this work is
therefore, to identify the region & and residues on ISU, in the yeast model (YIsu1), that
constitute this initial Fe binding site.

Site directed mutagenesis and subsequent

spectroscopic, calorimetric and kinetic analysis of the mutant proteins in comparison to
the wild-type (WT) and in the presence/absence of Frataxin were employed in this study.
These results aim to provide insight, at the atomic level, into the delivery of iron to YIsu1
and, subsequent loading of its cysteine rich active site. Contributors to this work were
Dr. Ashoka Kandegedara, a postdoctoral researcher in the Stemmler lab who designed
and performed a competition assay to determine Fe(ll) binding affinities of wild type
(WT) YIsu1 and mutants, graduate student Stephen Dzul, who aided in development of
a time-dependent Circular Dichroism assay to determine activity of Fe-S synthesis of
YIsu1 proteins, and a summer undergraduate student (2011-13), John Rotondo who
aided in protein purification and collection of Far UV CD experiments. This work is
being prepared for submission to the journal Biochemistry.
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3.2 Abstract
Eukaryotes utilize the protein ISU as a scaffold for the assembly of iron-sulfur
clusters within the mitochondria. Yeast Isu1 (YIsu1) contains three conserved cysteine
residues at its active site that coordinate the utilization of ferrous iron, Fe(II) and
inorganic sulfide, S2- for assembly into a 2Fe-2S cluster. We have previously shown
that YIsu1 binds two iron atoms with sub-micromolar to nanomolar affinity and that
YIsu1 interacts with the yeast Frataxin homologue 1 protein (Yfh1) in an iron-dependent
manner. Frataxin has since been described to participate in cluster assembly as an iron
donor and a pathway modulator. Although its function is essential, atomic details of its
interactions with partner proteins are still lacking. Recently, we have found by X-ray
absorption

spectroscopy

(XAS)

and

Mössbauer

spectroscopy

(manuscript

in

preparation) that YIsu1 binds iron in a 6 coordinate octahedral oxygen/nitrogen (O/N)
based ligand environment free of thiol ligation, indicating that YIsu1 binds Fe initially at a
site independent of the protein’s cysteine rich active site. In this report, we demonstrate
that the C-terminal residues of YIsu1 participate in iron loading leading to a possible
molecular rearrangement that drives a structural switch to enable iron translocation to
the thiol rich protein active site in order to accomplish Fe-S cluster assembly. Iron
binding competition assays and isothermal titration calorimetry experiments show a
reduction in the Fe(II) and Frataxin binding affinity for mutant YIsu1 forms (E144A and
D145A). Differential scanning calorimetry studies, comparing holo-WT YIsu1 to mutants,
show a change in stability and associated thermodynamic parameters. Finally, our in

	
  

	
  

	
  

59	
  

vitro Fe-S assembly assay shows mutant YIsu1 has a dramatically perturbed ability to
complete Fe-S cluster biosynthesis, as compared to the WT protein. Based on these
results, we speculate that the residues E144 and D145 on the YIsu1 C-terminal α-helix
serves as a possible initial iron-binding site on the scaffold protein, and that metal
delivered to this site can then be utilized for Fe-S cluster assembly.

3.3 Introduction
Iron sulfur (Fe-S) clusters are indispensible for life [1]. These inorganic cofactors
have a high degree of chemical versatility which allows them to participate, when bound
to proteins, in several reactions that include electron transfer (complex 1 & 2 of the
electron transport chain) [2], enzyme catalysis (mitochondrial Aconitase that functions in
glycolysis) [3], signal transduction (DinG that participates in DNA repair) [4] and sensing
of cellular metabolites such as oxygen and Fe content (Cytosolic Aconitase/IRP) [5, 6].
As these pathways are essential to sustain life, an inability to synthesize these clusters
is a condition that is incompatible to life [7].
The assembly of iron sulfur clusters occurs by a highly regulated protein
controlled process owing to the instability of the cofactor in aerobic environments and
the inherent toxicity of free iron and sulfide [8-10]. The formation of a multiprotein
complex ensures efficient production and delivery of clusters, while at the same time
actively suppresses free radical formation by free iron and the cyanide-like effects of
free sulfide [11].

	
  

In yeast, this complex is found within the mitochondria and is
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composed of the cluster assembly scaffold protein (Isu1), the cysteine desulfurase that
provides sulfur for cluster assembly (Nfs1), the Nfs1 accessory protein (Isd11), a
ferredoxin that provides reducing equivalents for cluster assembly (Yah1) and the
protein frataxin (Yfh1), which has been suggested to serve as an iron chaperone that
delivers Fe(II) for cluster assembly, a regulator of Nfs1 activity [12].

Defects or

deficiencies in these proteins have been associated with several human diseases [7,
13]. A deficiency of Frataxin causes the debilitating disease Friedreich’s Ataxia (FRDA),
associated with pooling of iron in the mitochondria of nerve and muscle tissues of
affected individuals leading to progressive neurodegeneration and cell death [14, 15]. In
addition to disrupted iron homeostasis, cardiac biopsies of FRDA patients exhibited
decreased activity of several Fe-S containing proteins, such as Aconitase, and proteins
of the electron transport chain involved in respiration, such as Complexes I, II & III [13,
16]. A genetic deficiency of ISU, caused by a splice-defect, has been reported to be
associated with muscular dystrophy in humans, due to a deficiency of Fe-S containing
proteins Succinate dehydrogenase and Aconitase [17, 18]. In yeast, Isu1 and 2 are
YIsu paralogs that show a combined deletion mutant lethality [19].
The active site of all Isu orthologs contains conserved cysteine residues that
coordinate the assembled iron-sulfur cluster [20]. Our XAS studies have shown that
YIsu1 binds iron at a site comprising a 6 coordinate O/N ligand environment [8]. In
addition, our XAS and Mössbauer studies on Fe(ll) bound to ISU proteins in the human,
fly and T. maritima orthologs show the same trend (chapter 2). This suggests ISU must
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bind iron at an initial acceptor site that is distinct from its Cysteine rich active site. The
occurrence of a distinction between a metal acceptance site from a substrate binding
site has been described previously for iron delivery to the protein Ferrochelatase that
participates in heme biosynthesis [21].
The crystal structure of IscU from Aquiflex aeolicus has shown distinct structural
differences in the IscU C-terminus dependent on the presence and absence of bound
cluster [20]. There appears to be an increase in order of the N-terminal region of the
IscU C-terminal helix coupled to cluster formation. Our previous studies have shown
that YIsu1 undergoes changes in fold upon substrate binding.

Using the ANS

chromophore, we have shown that binding of both Fe(ll) and S2- to Isu1 is associated
with an increase in order of the protein’s fold [8]. Recently, solution structural studies by
the Markley lab have shown that Isu does indeed exist in equilibrium between two
structural conformations: a "structured” (S) and “disordered” (D) states [22]. The D state
has been reported to be the substrate for Nfs binding. Cluster synthesis then drives the
protein to the S state, which is the substrate for co-chaperone proteins that remove the
cluster and drive the downstream delivery of cofactor to target apoproteins [23].
In this report, we study the properties of charged and conserved amino acid
residues on the YIsu1 C-terminus (residues E144 and D145) with regards to iron
binding, their interaction with Frataxin and Fe-S assembly.
mutagenesis, these residues were mutated to alanine.

Using site directed

Using competition-binding

studies, mutated proteins show a decrease in Fe(ll) binding affinity by up to 8 fold, in
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case of the E144A mutant, and up to 5 fold, in case of the D145A mutant. In addition,
interactions between these mutant proteins and holo-Frataxin, measured using
isothermal titration calorimetry (ITC), showed pronounced changes in binding
energetics. Differential scanning calorimetry (DSC) was used to test the stability of the
apo and holo forms of both WT and mutant protein. Finally circular dichroism (CD)
spectroscopy was used to test the overall fold of the mutants and to test the ability of
these mutants to synthesize Fe-S clusters. For Fe-S assembly, although WT YIsu1
showed an increased activity upon Frataxin binding, the D145A mutant protein behaved
differently in the presence of Frataxin, possibly due to changes in associated energetics
permitting assembly by an alternative mechanism. The involvement of these residues in
initial iron loading of YIsu1 is explored in detail below.

3.4 Materials & Methods
3.4.1 Site Directed Mutagenesis & Protein Expression:
Characteristics of expression and isolation of wild type YIsu1 have been outlined
within Chapter 2. The Quickchange site directed mutagenesis kit (Stratagene) was
used to make point mutations (E144A, D145A, and double mutant E144A, D145A) on
the pET21b plasmid containing the YIsu1 gene without the N-terminal targeting
sequence (Δ1-32 YIsu1).

Forward and reverse primers were designed using

Quickchange primer design program and were purchased from Invitrogen (Table 3.1).
Mutations were confirmed by DNA sequencing (Genewiz).

	
  

	
  

Plasmids containing the
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YIsu1 wild type (WT YIsu1) and mutant genes were transformed into BL21 codon plus
RIL cells (Stratagene) for protein expression. Cells were grown at 370C in Luria-Bertani
broth containing Ampicillin (0.1 μg/μl) and Chloramphenicol (0.05 μg/μl) with shaking
speed set at 250 rpm. At OD600 of 0.6, cells were induced for protein expression by the
addition of 0.8 mM IPTG.

Post induction expression conditions were found to be

optimum at a temperature of 37 0C, over a period of 3 hrs. following which the cells were
harvested by centrifugation and stored at -80 0C until lysis.

3.4.2 Protein Purification:
All protein isolation steps were carried out at 40C. Cells were re-suspended in
buffer containing 50 mM NaPO4 (pH 7.4), 300 mM NaCl, 10 mM Imidazole, 5 mM β-Me
(5 ml buffer/g cells) in the presence of lysozyme (100 μg/μl), a complete EDTA free
protease inhibitor tablet (1 tablet/ 50 ml, Roche), DNAse (10 μg/ml) and MgCl2 (5 mM),
and then allowed to incubate for ~15 mins. Cells were lysed by three passes through a
high-pressure homogenizer (Emulsiflex C3, Avestin) and centrifuged at 21,000 rpm for
one hour. The supernatant was separated and filtered using a 0.2 μm filter and the
crude soluble fraction was loaded onto a bench top column filled with Ni-NTA (Qiagen)
affinity resin. Using a stepwise imidazole gradient (20-500 mM), YIsu1 eluted at a
concentration of ~200 mM Imidazole. Fractions containing protein were pooled and
treated with 5 mM EDTA (overnight), followed by concentration to 1 ml using 10 KDa
cutoff Amicon filters and then loaded onto a Sephadex 75 gel filtration column (GE)
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Figure 3.1: Amino acid sequence comparison of the C-terminal region of Isu1
orthologs. Human (HsISU), Mouse (MmISU), Zebrafish (DrIsu), Bacteria (AvIscU) and
yeast (ScIsu1). Conserved residues in the proposed Fe binding site are in green and
pink while the c-terminal most conserved cysteine residues at the Isu active site is in
yellow.
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Table 3.1: List of primers used for Site Directed Mutagenesis

Primer Sequencea

Primer Name
YIsu1 E144A forward

5'-GCTCTATGTTAGCGGCAGATGCGATCAAGGC-3'

YIsu1 E144A reverse

5'-GCCTTGATCGCATCTGCCGCTAACATAGAGC-3'

YIsu1 D145A forward

5'-GCTCTATGTTAGCGGAAGCGGCGATCAAGGCAGC-3'

YIsu1 D145A reverse

5'-GCTGCCTTGATCGCCGCTTCCGCTAACATAGAGC-3'

YIsu1 E144A, D145A
forward

5'-GCTCTATGTTAGCGGCAGCGGCGATCAAGG-3'

YIsu1 E144A, D145A
reverse

a

	
  

5'-CCTTGATCGCCGCTGCCGCTAACATAGAGC-3'

Mutated residues are represented in italics and underlined.
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equilibrated with 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me. The protein
eluted at a volume corresponding to a dimer, pure fractions were pooled and protein
concentration was determined using IR Spectrometry (EMD Millipore Direct Detect).
Purification yielded about 2mg/ml of ≥95% pure protein from ~50 gm cells. Molecular
weights for WT YIsu1 and mutant proteins were confirmed by Mass Spectrometry
(Table 3.2).

3.4.3 Far UV Circular Dichroism:
Pure protein samples of 250-300 μl volume were dialyzed using 3.5 KDa cutoff
dialysis membranes (Spectrum Labs) into 1 mM NaPO4 (pH 7.5) buffer of 300 ml
volume for 3 hrs at 40C with 1 buffer change in between. Spectra were collected at a
concentration of both 10 uM and 25 uM using JASCO J-1500 CD spectrometer with a 1
mm pathlength cuvette over a range of 185-260 nm with a scanning speed of 50
nm/minute at room temperature. Prior to data collection, the instrument was baselined
without a cuvette to eliminate any background spectral contributions from the
instrument. Presented data represent an average of two independent preparations for
each protein sample, and each dataset is an average of 8-12 scans.

Data were

analyzed using the Spectra Analysis software provided by JASCO. Baseline correction
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Table 3.2: Masses of YIsu1 WT and mutants
Sample

Calculated Mass
(Da)

Experimental Mass
(Da)

WT

15515.9

15514.4a

D145A

15471.8

15471a

E144A

15457.8

15456.2a

E144A D145A

15413.8

15407b

a
b

	
  

Determined by ESI-MS
Determined by Average Mass Spectrometry

	
  

	
  

68	
  

was accomplished by subtracting an averaged buffer spectrum from each averaged
protein spectrum. Data were fit using the CD Pro fitting program provided by JASCO.
Reference databases for soluble proteins namely SP29, 37 and 43 were used and best
fits were obtained using the CONTIN method. Fits with the lowest RMSD values were
selected and averaged. CD curves were smoothed for display and secondary structure
percentages were tabulated from raw unsmoothed data. Standard deviations between
averaged runs are denoted in parenthesis
.
3.4.4 Isothermal Titration Calorimetry experiments & analysis:
The binding properties of YIsu1 WT and mutant proteins to Fe(ll) and to holo
Yfh1WT were tested using ITC.

Protein and aqueous ferrous ammonium sulfate

solutions were prepared anaerobically in a glove box (Coy Laboratories) in buffer
containing 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me. Protein samples
were maintained at 40C and buffers were extensively degassed prior to sample
preparation and loading. Holo Yfh1 was prepared by incubating equimolar amounts of
Yfh1WT and Ferrous Ammonium Sulfate solution 15-30 minutes prior to use. ITC data
were collected on a TA Instruments Nano ITC calorimeter located within the Coy
anaerobic chamber by titrating 1 mM holo Yfh1 WT into a 1.3 ml volume of 50 uM
protein solution. Data collection parameters followed a 2 μl initial injection of titrant
solution followed by 35 additional injections of 7 μl using a 250 μl syringe. Injections
were spaced at 10 minutes each and data was collected at 300C with stirring speed set
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at 250 rpm.

Control experiments of 1 mM holo Yfh1WT titrated into buffer was

subtracted from the experimental data to eliminate background heats of dilution. Data
analysis was performed utilizing the Nano Analyze software provided by TA instruments
using a multiple sites model for curve fitting and analysis.

All experiments were

performed in duplicate on independent samples to ensure data reproducibility.
3.4.5 Competition Assay:
The affinity of WT YIsu1 and mutants proteins for Fe(II) was determined by
competition titrations using Mag-fura-2 (Molecular Probes), a well-known metal chelator
that binds ferrous iron. Mag-fura-2 forms a 1:1 complex with most divalent cations and
has an absorbance maximum at 366 nm that shifts to 325 nm when metal is bound.
The decrease in absorbance at 366 nm as Mag-fura-2 binds increasing amounts of Fe
(II) in competition with the protein was monitored on a Shimadzu UV-1800
spectrophotometer using 1 cm pathlength quartz cuvettes. Data were collected at room
temperature within an anaerobic chamber (Coy Laboratories).

Mag-fura-2 was

dissolved in high purity MiliQ water and stored at -80⁰C in 10 μL aliquots of 2 mM stock
concentration. Protein samples and ferrous ammonium sulfate solutions were prepared
in buffer containing 20 mM HEPES (pH 7.5) and 150 mM NaCl. Prior to use, protein
samples were reduced with 5 mM TCEP. All protein samples, reagents and buffers
were allowed to incubate at 40C overnight in an anaerobic chamber before data
collection. For the control reaction, the initial starting solution contained 2-5 µM Magfura-2 in 1 ml of reaction buffer, aliquots of Fe (II) of varying volumes were then titrated
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until saturation. Each spectrum was collected from 200-800 nm for each ‘i’th addition of
metal aliquot. Dilution correction was performed by carrying out the same experiment
using buffer instead of Fe(II). For protein titrations, the same procedure was followed
except that 10-20 µM of protein was mixed with Mag-fura-2 at the beginning of the
binding reaction.

Metal free Mag-fura-2 concentrations was confirmed using the

molecules’ molar absorptivity (ε) value at 366 nm that is 29900 M-1cm-1 [24].

The

dissociation constant of Fe (II)-Mag-fura-2 complex under the above buffer conditions
was determined to be 2 (±0.07) μM. Data were fit using the program DYNAFIT [25] with
both one and two-site binding models. Our reported Kd values are an average 3 runs.

3.4.6 Differential Scanning Calorimetry experiments & analysis:
Thermal stability of the WT- and mutant YIsu1 samples in the absence and
presence of iron were evaluated using a VP Differential scanning calorimeter (TA
Instruments) to determine stability parameters associated with the mutants in the apo
and holo forms.

Protein and iron solutions were prepared anaerobically in 20 mM

HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me. Buffer was extensively degassed prior
to sample preparation and loading. Protein concentrations of 1.25 -1.5 mg/ml were
used and iron solution was added to obtain samples upto a 1:2 protein:Fe ratio and
made up to a final volume of 600 μl. YIsu1 WT remained stable upon addition of Fe,
however slight precipitation was observed among the mutants, which was removed by
centrifugation, and the change in protein concentration was noted. Scans were run at a
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rate of 20C per min over a temperature range of 10-900C, while pressure was
maintained at an excess of 2.95 atm throughout the scan period. Data obtained were
analyzed using the Nano Analyze software provided by TA Instruments. Data was
baseline subtracted using control runs of buffer alone or buffer with iron at
concentrations that matched the amount in protein samples. Peak deconvolution was
achieved using the two state scaled mathematical model that incorporates the Aw factor,
which accounts for inaccuracies in protein concentration upon denaturation.

Data

presented represents an average of two independent samples.

3.4.7 Near UV CD for Assembly Activity:
The cluster reconstitution of apo WT YIsu1 and mutants was tested by time
course CD spectroscopy.

All proteins, reagents and the buffer solution of 20 mM

HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me, were allowed to incubate overnight in
an anaerobic chamber. Protein and buffer were maintained at a temperature of 40C
overnight.

All solutions were prepared in the above-mentioned buffer within the

anaerobic chamber immediately prior to data collection. The reaction mixture consisted
of 100 uM apo YIsu1 WT or mutant, 200 uM ferrous ammonium sulfate solution or 200
uM holo Yfh1 (prepared by incubating equimolar concentrations of Yfh1 and Fe(ll) for
15-30 minutes prior to use) and 1 M Na2S solution made up to a final volume of 1.2 ml.
Data was collected on a JASCO J-1500 CD spectrometer at room temperature with a 1
cm pathlength cuvette, which was capped to eliminate any air induction. The instrument
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was baseline subtracted without a cuvette prior to data collection to eliminate any
background spectral contributions from the instrument. Data was recorded over 300700 nm and 2 scans were collected at a scanning speed of 100 nm/min; these scans
were then averaged. The mixture was subjected to agitation using a magnetic stir bar
for 30 seconds prior to data collection. Scan sets were collected every 10 minutes until
signal saturation was observed.

Data were averaged using the Spectra Analysis

software provided by JASCO. The absorbance signal at 435 nm was used for activity
plots of absorbance v/s time, plotted using Kaleidagraph.

3.5 Results
3.5.1 Mutant proteins have a similar fold as wild-type (WT) YIsu1:
Far UV CD spectroscopy was used to compare the relative protein fold of WT
and mutant Isu1 proteins. WT and mutant YIsu1 proteins were all well folded with a
similar secondary structural content. Far UV CD results showed the presence of two
predominant secondary structural features: α-helix (positive feature at 192 nm and
negative at 208 nm & 222 nm) and β-sheet (negative feature at 218 nm and positive at
196 nm) [26] in WT YIsu1 and to a similar degree in the mutant spectra (Figure 3.2).
The wild type protein shows a secondary structural makeup of 20 (± 7)% α-helix, 26 (±
7)% β-sheet, 22 (± 1)% turns and 32 (± 1)% unordered (Table 3.3) with an RMSD
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Figure 3.2: Far UV Circular Dichroism spectra of apo YIsu1 WT and mutants.
Data were collected at room temperature over a wavelength range of 190-260 nm in
1mM NaPO4 (pH 7.5). The panels below represent: (A) WT (B) E144A (C) D145A (D)
E144A, D145A YIsu1 spectra.
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Table 3.3: Secondary structural features from simulation of CD spectra for YIsu1
WT and mutant proteins
% Fold with standard deviation
WT
E144A
D145A
E144A, D145A
Helix
20(±7)
26(±2)
22
21(±4)
Sheets
26(±7)
20(±2)
23
26(±3)
Turns
22(±1)
23(±1)
23
22
Unordered
32(±1)
31(±1)
32
31(±1)
TOTAL
100
100
100
100
b
RMSD
0.07
0.07
0.07
0.05
a
Circular Dichroism data collected in 1mM NaPO4 (pH 7.5) from 190-260nm
b
% error between experimental and calculated values
Secondary
Structurea
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between data and simulation of 0.07 ± 0.007 corresponding to an error of ca. 7% which
is the difference between the calculated and experimentally determined CD spectrum.
Minor differences in simulation parameters observed between WT and mutant proteins
include a reduction of up to 6% in β-sheet content for the E144A protein and 3% for the
D145A protein with a corresponding increase in α-helical content suggesting a slight
change in fold for the mutants. Secondary structural simulations for the double mutant
are almost identical to the WT protein.
YIsu1 WT showed the highest standard deviation of approximately 7% between
averaged runs for α-helix and β-sheet secondary structures, while the D145A mutant
showed no change in secondary structure between averaged runs.

3.5.2 YIsu1 mutants show a decreased Fe(ll) binding affinity:
As the environment within a cell contains several potential metal ligands, using
chelators that compete with the protein of interest for metal binding has been reported to
be a more relevant method of obtaining a more physiological binding constant for
protein-metal binding [27]. In this report, we have used the chelator Mag-fura-2 as a
competitor for Fe(ll) binding with WT YIsu1 and mutant proteins.

The metal-free

chelator has an absorbance maximum at 366 nm, which decreases upon increasing Fe
(ll) binding, and this is monitored by UV-Visible spectroscopy [24] (Figure 3.3, inset).
Data obtained were fit using the program DYNAFIT [25]. Initial titrations of Fe(ll) to
Mag-fura-2 were best fit to a one-sites model with a KD of 2.00 (±0.07) μM under these
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experimental conditions.

Isu proteins have reported KD values in the nanomolar to

micromolar range [8, 28], therefore a competition between the two ligands for Fe(ll) can
be envisioned. Using this assay, WT YIsu1 was best fit with a two-sites model with
binding affinities in the micromolar range at both sites of KD1 2.38 (±0.85) μM and a KD2
of 4.55 (± 2.69) μM.

The one-sites fit had large estimated errors (Table 3.4).

Previously reported values using isothermal titration calorimetry (ITC) indicate binding
affinities for YIsu1 in the nanomolar to micromolar range [8].

However using Trp

fluorescence, micromolar binding affinities for Tm IscU were reported using a two-site
model for fitting [28].

As ITC measures total heat, we speculate the possibility of

contributions due to conformational changes in the protein upon substrate binding. The
mutant protein E144A was best fit with a two-sites model and showed a slight rise in KD1
of 4.95 (± 0.91) and an eight-fold rise in KD2 of 38.1 (± 22) compared to the WT protein.
Again the one-sites fit had high estimated errors. The D145A mutant showed a similar
trend with a slight rise in KD1 of 7.60 (± 2.60) and six-fold rise in KD2 of 26.2 (± 12.1)
compared to WT.

This mutant however, yielded an acceptable fit with a one-sites

model. Finally, the E144A, D145A mutant was best fit with a one-sites model with a KD
of 3.15 (± 1.43). Fits with a two-sites model yielded high errors. As the single mutant
proteins were associated with a significant drop in binding affinities associated with one
of the sites, with the other site being largely unaffected, these results suggest the
possible loss of one Fe(ll) binding site.
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Figure 3.3: Competition Assay between Mag-fura-2 and YIsu1 proteins with
Fe(II). (A) Data was fit with DYNAFIT. Curves correspond to WT YIsu1 13 µM
and 5.5 µM Mag-fura-2; D145A 10.3 µM and 9.4 µM Mag-fura-2; E144A 5.4 µM
and 3.9 µM Mag-fura-2; E144A, D145A 8.0 µM and 3.3 µM Mag-fura-2. Fe(ll) was
titrated in increasing concentrations. (B) Inset: Initial absorbance spectra
obtained during titration of 5 µM of Mag-fura-2 and 15 µM WT YIsu1 Fe (II) in 20
mM HEPES (pH 7.5), 150 mM NaCl, at 25⁰C. The arrows denote the direction of
the absorbance changes with increasing concentrations of Fe(II).
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Table 3.4: KD values obtained from Mag-fura-2 assay for WT YIsu1 and mutant
proteins. Data was fit to two binding site model using DYNAFIT and average values of
(n=3). KD1 and KD2 are given with errors for YIsu1 monomer in 20 mM HEPES (pH 7.5)
150mM NaCl and 5 mM TCEP, at 25 ⁰C.

	
  
YIsu1 Protein

KD1 (µM)

KD2 (µM)

KD One -sites

WT

2.38 ± 0.85

4.55 ± 2.69

-a

E144A

4.95 ± 0.91

38.1 ± 22.0

12.0 ± 14.0

D145A

7.60 ± 2.60

26.2 ± 12.1

3.96 ± 0.77

-a

3.15 ± 1.43

E144A,D145A
2.99 ± 0.11
a
Error associated with fit were very high.
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3.5.3 Thermal Stability of YIsu1 proteins by Differential Scanning Calorimetry
(DSC):
The changes observed above in number and affinity of ligand and protein partner
binding characteristics of YIsu1 mutants in comparison to WT possibly arise due to
changes in energetics at the binding interface with Fe(ll) and/ or due to global changes
in the stability & dynamics of the C-terminal helix. DSC is a sensitive technique that can
be used to study the changes in protein stability and associated energetics upon residue
mutation and was applied to study YIsu1 WT and mutants in the absence (Apo) and
presence (Holo) of Fe(ll). ‘Holo’ protein refers to protein pre-loaded with two equivalents
of Fe(ll) to maintain consistency with YIsu1’s maximal Fe(ll) binding ability.

All

experiments were performed anaerobically in duplicate with independent protein
preparations. Data were fit using the two-state scaled model. The approximation of
enthalpy values i.e., ΔHcal (kJ/mol), obtained upon peak integration, to the Van’t Hoff
enthalpy ΔHvH (kJ/mol), obtained upon model fitting is used an indicator of validity of
the model to the system that it is applied to i.e.
ΔHcal = ΔHvH or
ΔHcal /ΔHvH = 1. [29]
Apo WT alone, and mutant proteins both; in the apo and holo form were best fit with two
two-state transitions possibly corresponding to an equilibrium between structured and
disordered states as previously reported for Isu proteins [22]. The apo proteins showed
varying percentages of the two states (grey fits, Figure 3.4). Holo WT alone was best
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fit with a single transition indicating almost a 100% switch in protein structure upon Fe(ll)
binding. For Apo WT, temperature maximum for the first transition was 47.34 ± 0.380C
and the second transition was 51.36 ± 0.260C. Holo WT melted at a higher temperature
of 54.65 ± 0.060C indicating a significant increase in stability upon Fe(ll) binding with an
associated shift in structure that does not significantly disrupt the associated enthalpy or
entropy compared to apo WT (Table 3.4). The E144A mutant showed a slight increase
in stability of both the apo and holo forms compared to WT. This mutant has previously
been reported to stabilize the Isu fold in the structured state in E.coli [22]. In the apo
form, temperature maximum for the first transition was 51.00 ± 1.200C and second
transition was 53.60 ± 0.900C, an approximate 3 degree shift toward stability compared
to WT. The holo form was more stable, but was fit with a two-state transition, unlike holo
WT and appeared to be in equilibrium between two states: a smaller percentage that
melted at temperatures similar to holo WT i.e., 54.65 ± 0.060C while majority of the
protein was associated with an even more stable state that melted at 61.07 ± 0.280C.
Holo E144A was also associated with a four-fold rise in enthalpy and entropy compared
to the apo form indicating Fe(ll) binding was an enthalpically unfavorable, yet
entropically favorable reaction. Apo D145A exhibited a melting temperature that was
similar to apo WT however, the holo form on the other hand was associated with a
decrease in stability. The temperature maximum for holo D145A upon Fe(ll) binding
dropped to 42.68 ± 0.370C for the first transition and 49.50 ± 0.160C for the second
transition. Enthalpy and entropy showed a three-fold increase in the holo form
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Figure 3.4: Thermal denaturation curves for apo and holo YIsu1 proteins. Data
collected using a Nano DSC instrument over 10-900C at a scan rate of 2 0C/ min in 20
mM HEPES (pH:7.5) 150 mM NaCl & 5 mM β-Me at excess pressure of 2.95 atm for
WT YIsu1 (A) and mutants E144A(B), D145A(C) and double mutant E144A, D145A(D).
‘Holo’ refers to protein pre-loaded with 2 equivalents Fe(ll), Apo protein curves are offset
for clarity. Black solid lines represent the fit to raw data, black dashed lines represent
raw data, and grey solid and dashed lines represent deconvolution of raw data using the
two-state scaled model.

	
  

	
  

	
  

Table 3.5: Thermodynamic parameters of melting of WT YIsu1 and mutant proteins. Tmfit1 & 2 and
represent temperature maximum for each transition fit to raw data. ΔHvH represents Van't Hoff enthalpy
which is total enthalpy under each fit obtained upon correction with scaling factor Aw. ΔHcal, ΔScal and
Tmax represent enthalpy, entropy and maximum temperature obtained from peak integration after
baseline correction of raw data. Values for ΔHvH, ΔHcal and ΔScal show a similar trend between
datasets.

YIsu1 variant

B) E144A
C) D145A
D) E144A,
D145A

Tmfit1
0

Tmfit2
0

TMax
0

ΔHvH

ΔHcal

ΔHcal/

ΔScal

Apo

( C)
47.34 ± 0.38

( C)
51.36 ± 0.26

( C)
51.26

(kJ/mol)
8.40

(kJ/mol)
7.94

ΔHvH
0.95

(kJ/mol.K)
0.025

Holo
Apo

51.00 ± 1.20

54.65 ± 0.06
53.60 ± 0.90

55.29
51.92

5.76
4.48

5.10
3.97

0.90
0.89

0.016
0.012

Holo
Apo

54.63 ± 0.58
48.38 ± 0.50

61.07 ± 0.28
51.79 ± 0.15

60.82
50.86

18.85
25.76

18.40
25.98

0.98
1.01

0.055
0.080

Holo
Apo

42.68 ± 0.37
43.92 ± 0.43

49.50 ± 0.16
47.85 ± 0.80

48.76
45.32

66.33
9.23

63.63
8.29

0.96
0.90

0.200
0.026

Holo

51.26 ± 0.30

61.72 ± 0.18

61.46

21.35

20.76

0.97

0.018
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A) WT

State
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compared to apo D145A. Both apo and holo D145A proteins were fit with two two-state
models with no apparent variation in the percentages of each state. The double mutant
E144A, D145A showed a decreased stability in the apo form. Temperature maximum
for the first transition was 43.92 ± 0.430C and the second transition was 47.85 ± 0.800C.
Fe(ll) binding showed a melting pattern with an increased stability and was fit with two
two-state transitions in a manner similar to that of holo E144A. The holo form, just like
the single mutants was associated with an three fold increase in enthalpy compared to
its apo form, however, the associated entropy appeared to be similar to that of WT. The
rise in molar heat capacity in Figure 3.4 upon Fe(ll) binding in the mutant proteins can
be attributed to thermodynamic changes in enthalpy and entropy.

3.5.4: YIsu1 mutant proteins show altered holo-Yfh1 WT binding:
ITC was performed to study the binding affinity, binding ratio and thermodynamic
parameters associated with the interaction between holo-yeast frataxin (Yfh1WT) with
WT YIsu1 and mutant proteins (Figure 3.5). Our previous studies have shown that
Yfh1WT and WT YIsu1 do not interact in the absence of Fe(ll), therefore all experiments
described below were performed using holo Yfh1WT prepared as described above in
the materials & methods section [8]. All data was collected anaerobically on a TA NanoITC instrument and in duplicate on independent protein samples to ensure
reproducibility. Prior to fitting and analysis, a control experiment of 1 mM holo-Yfh1WT
titrated into buffer was subtracted from the raw data. The binding of holo-Yfh1WT to
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Figure 3.5: Holo-Yfh1 to YIsu1 protein titrations: Raw ITC data (top) and binding
isotherm data after control subtraction (bottom) of holo yeast frataxin (Yfh1WT) binding
to (A) YIsu1 WT (B) YIsu1 D145A (C) YIsu1 E144A, D145A. The black solid line in the
binding isotherm panel represents the simulated fit to the data after control subtraction.
	
  

	
  

Table 3.6: Average Simulation Results using ITC Analysisa for WT YIsu1 and mutant proteins
Sample

N1

KD1 (nm)

N2

KD2 (μM)

dH1
(KJ/mol)

dH2
(KJ/mol)

dS1
(J/mol-K)

dS2
(J/mol-K)

0.20 ± 0.07

2.94 ± 1.79

2.13 ± 0.94

0.11 ± 0.06

-1.61 ± 0.46

-0.52 ± 0.50

144 ± 21.51

81 ± 78.17

D145A -- Fe-Yfh1

0.20 ± 0.01

95.2 ± 77.9

0.85 ± 0.07

2.91 ± 2.54

1.01 ± 0.13

1.63 ± 0.67

139 ± 6.93

113 ± 6.36

E144A, D145A -- FeYfh1

0.34 ± 0.02

51.5 ± 15.4

0.68 ± 0.01

0.86 ± 0.02

2.45 ± 0.07

1.26 ± 0.18

148 ± 2.83

120 ± 0.85

a

Averaged values of stoichiometry v/s the Isu1 monomer.
N1, N2, dissociation constants KD1, KD2, enthalpy dH1, dH2 and entropy values dS1, dS2 are given with errors.
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WT -- Fe-Yfh1
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WT YIsu1 follows an exothermic pattern with an initial exponential binding curve
followed by a constant heat release pattern consistent with sample dilution in the post
saturation stage. Data was best fit using the multiple sites model with a total of two
binding molecules at two binding affinities of 2.94 (±1.79) nM and 0.108 (±0.06) μM.
This interaction is both enthalpically (dH1 is -1.61 ± 0.46 KJ/mol and dH2 is -0.52 ± 0.5
KJ/mol) and entropically favorable (dS1 is 144 ± 21.51 J/mol.K and dS2 is 81 ± 78.17 J/
mol.K). Binding of holo Yfh1WT to YIsu1 mutant E144A demonstrated a heat release
pattern that was similar to the control experiment. Subtraction yielded a flat line with no
measurable affinities or thermodynamic parameters (data not shown).

In contrast,

binding of both: the mutant D145A and the double mutant E144A, D145A yielded an
endothermic pattern of heat release and were best fit with a multiple sites binding model
with a total binding of approximately one molecule.

The D145A mutant showed

approximately a thirty-fold decrease in binding affinities at both sites compared to YIsu1
WT of 95.2 (±78) nM and 2.91 (±2.54) μM at the second site. This interaction though
not enthalpically favourable (dH1 is 1.01 ± 0.13 KJ/mol and dH2 is 1.63 ± 0.67 KJ/mol)
was entropically favorable (dS1 is 139 ± 6.93 J/mol.K and dS2 is 113 ± 6.36 J/mol.K).
The E144A, D145A double mutant showed binding affinities that were decreased, but to
a lesser extent as compared to the D145A mutant with KD values of 51.5 ± 15.4 nM at
one site and 0.85 ± 0.02μM at the second site. Again, as in the case of the D145A
mutant, this interaction was not enthalpically favorable (dH1 is 2.45 ± 0.07 KJ/mol and
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dH2 is 1.26 ± 0.18 KJ/mol) but was entropically favorable (dS1 is 148 ± 2.83J/mol.K and
dS2 is 120 ± 0.85 J/mol.K).

	
  3.5.5 YIsu1 mutant shows altered Fe-S assembly activity:
Protein bound 2Fe-2S clusters yield a characteristic signature spectrum in the
near UV region (300-700 nm) using circular dichroism [30]. Owing to its sensitivity, this
technique was employed to test the ability of WT YIsu1 and the D145A mutant to
synthesize clusters: either in the presence of holo Yfh1WT or just Fe(ll) alone.

A

previously published protocol [31] was modified such that the reaction mixture contained
100 μM WT YIsu1 or D145A mutant, 200 μM holo-Yfh1 (prepared as mentioned above)
or 200 μM Fe(ll) alone. The reaction was initiated by adding 1 mM Na2S in a final
volume of 1.2 mL. The concentration of Na2S was optimized to minimize contamination
by a ferrous sulfide species that forms upon mixing. Controls containing either holoYfh1 or Fe (ll) alone mixed with Na2S in buffer and in the absence of YIsu1 was tested
and yielded no characteristic spectrum (data not shown).

The mixture was slowly

agitated by stirring with a magnetic stir bar for 30 seconds in between data collections.
A set of two scans were collected over 10 minutes and averaged. Data was collected
for approximately 100-120 minutes or until signal saturation was observed. In Figure
3.5, panel A shows the activity plot of WT YIsu1 and panel B shows the activity plot of
the YIsu1 D145A mutant in the presence of holo Yfh1WT () and Fe(ll) alone (). In the
inset are displayed the CD data
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Figure 3.6: Fe-S assembly activity of WT YIsu1 and mutant D145A: on YIsu1
WT (A) or the D145A mutant (B) by near UV circular dichroism. The solution
contained 100 μM YIsu1 protein in 20 mM HEPES (pH: 7.5) 150 mM NaCl 5 mM
β-Me buffer to which 100 μM Fe (ll) was added either as holofrataxin ( and inset
panel ‘a’) or alone (wand inset panel ‘b’). Reaction progress was monitored from
300-700nm over time until saturation. CD data at 435nm was plotted over time to
obtain activity plots. Error bars represent average values at each time point from
two independent reproducible experiments collected.
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collected in the presence of holo Yfh1 WT, panel ‘a’ and in the presence of Fe(ll) alone,
panel ‘b’. In the presence of holo Yfh1 WT, YIsu1 shows activity that is approximately
two fold higher than its activity in the presence of Fe(ll) alone.

The reaction with

Frataxin also appears to proceed at a faster rate compared to that with Fe(ll), evident
from the initial phase of the reaction (initial 20 mins.) which occurs on a shorter time
scale. This clearly indicates a stimulation of YIsu1 WT activity in the presence of holo
Yfh1WT. In contrast, the D145A mutant showed a higher activity in the presence of Fe
(ll) alone. The reaction, although slower was more active in the synthesis of clusters
than the reaction with Frataxin alone which reached saturation earlier.

This

phenomenon could be due to diminished interaction of the D145A mutant with Yfh1WT
and altered energetics associated with the synthesis of Fe-S clusters.

3.6 Discussion:
There has been much speculation over the role of Frataxin in the ISC multiprotein
complex.

So far, its functions that have been described include a role as the Fe

chaperone for iron-sulfur cluster synthesis where it functions in delivering iron to ISU for
cluster assembly [8, 31, 32] and as a modulator of the cysteine desulfurase enzyme in
Fe-S assembly [33]. Frataxin and ISU are known to be stable binding partners within
and outside of the ISC complex [8, 10, 32-34]. This interaction has been demonstrated
both genetically and in vitro and has been shown to be iron dependent [8, 35].
However, the initial events of Fe acceptance by ISU and its subsequent incorporation
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into Fe-S clusters are yet unclear. In this study we further examine the interaction
between Frataxin and ISU with a focus on ISU. Unpublished XAS and Mössbauer
results from our lab carried out on four ISU orthologs namely yeast, human, fly and
Thermatoga all show that Fe (ll) is bound in a 6-coordinate oxygen/nitrogen ligand
environment [8] indicating that the Fe delivery/acceptance occurs at a site that is
different from ISU’s cysteine rich active site. The presence of alternative metal binding
and substrate binding sites on the same protein has previously been described for
Ferrochelatase, the enzyme that inserts Fe into heme [21]. ISU is a molten globule
protein with a hydrophobic interior and it has been previously described that the
synthesized Fe-S cluster is buried within a solvent inaccessible region in the
multiprotein complex [8] possibly precluding a release of reaction intermediates that
may endanger the mitochondrion.

Under such circumstances, the occurrence of a

separate metal binding site in a region that is accessible to solvent and/or protein
binding partners is feasible. The assembly of Fe-S clusters by ISU involves changes in
fold within the protein. The Markley group has demonstrated that bacterial IscU exists
in an equilibrium between structured (S) and disordered (D) states and that the (D) state
is the substrate for cysteine desulfurase binding [22]. Using fluorescence anisotropy,
research from our group has reported structural changes in yeast Isu1 upon binding of
Fe and S2- [8]. These results indicate that substrate binding drives structural changes in
ISU. This fact has been further corroborated by the crystal structure of IscU from the
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bacterium A. aeolicus which shows an increase in order of fold of the C-terminus upon
cluster assembly [20].
In this study we replaced conserved, charged residues E144 and D145 on
YIsu1’s C-terminal helix with an uncharged alanine residue by site directed
mutagenesis. We have previously shown by NMR that charged residues on frataxin’s
α1/β1 acidic ridge along with a portion of its β-sheet forms the interface of frataxin with
ISU [8]. These regions also include frataxin’s Fe binding residues [36]. A closer look at
the IscU-IscS crystal structure from the Cygler group shows that IscU interacts with IscS
in the proximity of its active site, leaving the c-terminal helix open and solvent exposed.
Predictive modeling of CyaY on the IscU-IscS structure showed that CyaY possibly
binds IscS in a region close to the IscU binding site and appears to be in a region that
also overlaps the IscU C-terminus [9]. Charged residues on IscU’s c-terminus would
provide a complementary charged binding surface to frataxin promoting electrostatic
interactions that could aid Fe delivery.
Far UV circular dichroism did not show major deviations in secondary structure
between the wild type protein and mutants. Compared to the wild type protein, the
E144A and D145A single mutants both showed a slight increase in helical content of 6%
and 3% respectively with a corresponding drop in β–sheet content indicating a
possibility that these mutants have a greater helical fold compared to the WT protein
and that in the WT protein, these mutants possibly destabilize the C-terminal helix. The
fact that the E144A mutant stabilizes the protein fold has been previously shown by the
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Markley group in bacterial IscU (corresponding residue E111A) [22]. A double mutation
in the area appears to restore WT folds as indicated by the E144A, D145A mutant.
Competition binding assays with Mag-fura-2, used to test the Fe(ll) binding ability
of WT YIsu1 and mutant proteins showed binding affinities in the micromolar range for
both sites. Using isothermal titration calorimetry, we observe nanomolar to micromolar
binding affinities when YIsu1 binds Fe(ll) [8]. As ITC measures total heat, we speculate
the occurrence of contributions from heats due to conformational changes on Isu in
addition to heat released upon Fe(ll) binding. As the mutant proteins all showed a drop
in binding affinities at one of the sites with the second site being only marginally
affected, we can conclude that these residues are possibly involved in Isu’s initial iron
binding site.
The thermal stability and associated energetics of the apo- and holo-forms of WT
and mutant proteins were also tested by differential scanning calorimetry.

Melting

curves of the apo forms of both WT and mutant proteins showed two distinct transition
temperatures, which could possibly correspond to denaturation of the structured and
disordered forms of the protein [22]. The holo form of WT YIsu1 alone could be fit with a
single transition state indicating almost 100% shift to a higher, single melting
temperature brought about by a stabilizing change in protein structure accompanied by
Fe(ll) binding.

The melting of the protein at two distinct temperatures during

denaturation has been recently reported by the Pastore group in as-purified bacterial
IscU at a 30 fold EDTA excess, in addition, a stabilizing change accompanied with a
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shift to a higher melting upon Zn binding was also shown [37]. Among the mutant
proteins, apo D145A melted at a temperature similar to WT, while the holo form
underwent a destabilizing change upon Fe(ll) binding evident by a shift to lower melting
temperature. The E144A mutant was intrinsically more stable, the apo form melted at a
temperature that was three degrees higher that WT. Holo E144A appeared to be in
equilibrium between two stable states, one at a temperature similar to holo WT YIsu1
and another at a higher temperature. As previously described, the E144A mutant has
been described as a mutant that stabilizes the S-state [22], which possibly is a reason
for the observed higher than WT stability. The apo form of the E144A, D145A mutant
had a lower stability than WT, however Fe(ll) binding was associated with a stabilizing
switch to higher temperatures in a manner similar to the E144A single mutant possibly
reflecting the stabilizing change observed in the single mutant. These results clearly
indicate a stabilizing change in YIsu1 structure upon substrate, Fe(ll) binding.

In

addition, the inability of the D145A mutant to make the switch to a more stable fold
would implicate this residue in in metal binding. Thermodynamic parameters associated
with the unfolding of WT YIsu1 showed that denaturation of holo WT YIsu1 was not
accompanied by any significant changes in enthalpy and entropy indicating that the
structural change possibly balanced out energetic changes associated with Fe(ll)
binding. The denaturation of apo D145A was associated with an increased enthalpy
compared to apo WT indicating a possible intrinsic change within the protein structure.
However, the denaturation of the holo forms of all the mutant proteins was accompanied
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by significant increases in both enthalpy and entropy indicating an enthalpically
unfavorable yet entropically favorable process, distinct from WT YIsu1.
The holo Yfh1WT binding ability of WT YIsu1 and mutant proteins was also
tested by isothermal titration calorimetry. Binding of WT YIsu1 to holo Yfh1WT was
associated with much tighter binding affinities than those previously published for Fe(ll)
alone [8], indicating a strong binding interaction with holo Yfh1WT. Binding affinities,
unlike the UV-Vis method were of two distinct types: a tighter nanomolar affinity and a
lower micromolar affinity. Compared to WT, binding of mutant proteins D145A and
E144A, D145A was associated with a decrease in binding affinity of up to 30-fold in the
D145A mutant and approximately 20-fold in the double mutant at the higher affinity site.
The lower affinity site was also associated with decreased affinities, however to a less
severe extent. In addition, decreased binding affinities were associated with a decrease
in stoichiometry of binding indicating a weak interaction. For E144A binding to holo
Yfh1WT, the binding isotherm was similar to the buffer control yielding no measurable
binding affinity upon buffer subtraction.

Mutant proteins D145A and E144A, D145A

binding holo-Yfh1 followed an endothermic trend as opposed to the exothermic trend
observed with WT YIsu1 binding. Associated changed with thermodynamic parameters
were also observed. WT YIsu1 binding holo Yfh1 was enthalpically favorable however
mutant binding to holo frataxin was associated with a rise in enthalpy i.e. was an
enthalpically unfavorable change. Entropy and free energy values for both WT and
mutant YIsu1 however, remained similar. These results indicate a) that holo Yfh1WT
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binding is an enthalpically favorable process possibly characterized by electrostatic
interactions and hydrogen bonding, an enthalpically favorable process has also been
described for holo Drosophila frataxin binding Isu1 [31] and that b) these residues,
particularly the D145A mutant is required for both Fe binding, and holo-Yfh1 interaction,
possibly forming the interface between Yfh1WT and WT YIsu1 and c) mutations at
these regions are associated with a change in thermodynamic properties associated
with Fe(ll) binding that are enthalpically unfavorable.
Finally, the ability of WT YIsu1 and the D145A mutant to synthesize clusters was
tested by time course far UV circular dichroism spectroscopy in the presence of either
Fe(ll) alone or holo Yfh1WT. WT YIsu1 showed a twofold increase in cluster synthesis in
the presence of holo Yfh1WT, indicating a direct stimulation of YIsu1 activity in keeping
with its role as an Fe chaperone. In contrast, the D145A mutant showed an increase in
activity in the absence of holo Yfh1WT, though the reaction progressed at a slower
pace. Fe(ll) binding experiments showed a decrease in affinity at one site while the
second site which is possibly the active site, appeared to retain binding properties which
could explain the ability of the mutant to synthesize clusters. ITC experiments of holoYfh1 binding to the D145A mutant showed a weak interaction with altered energetics
associated with binding. In the presence of holo Yfh1, the reaction with D145A reached
equilibrium faster possibly due to saturation of the active site by additional interactions
mediated by frataxin. In the absence of frataxin, one can envision the active site being
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populated at a slower pace in the absence of the initial binding site hence, saturates
later.
These results lead us to postulate a model for the initial binding events of Fe-S
cluster assembly.
1) Holo-frataxin appears to activate Fe-S assembly therefore an iron dependent
interaction between frataxin & ISU appears to be essential for efficient cluster
synthesis.
2) Initial metal binding is facilitated by electrostatic interactions between charged
residues at the interface of holo-frataxin and ISU at Isu’s c-terminus, and is an
enthalpically favorable process. The D145A residue appears to play a critical
role in this process.
3) This is followed by a structural change in ISU that possibly favors hydrophobic
interactions within the protein and facilitates Fe-S synthesis.
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CHAPTER 4
DROSOPHILA FRATAXIN CRYSTAL STRUCTURE, RESONANCE ASSIGNMENTS
AND PUTATIVE IRON BINDING RESIDUES
4.1 Prelude
Friedreich’s ataxia (FRDA) is caused by a patient’s inability to produce a viable
form of the mitochondrial protein frataxin.

Frataxin’s involvement in cellular iron

regulation became evident by the observed accumulation of large amounts of iron in
actively metabolizing cells of individuals suffering from FRDA. Frataxin has since been
shown to participate in several capacities related to regulating cellular iron homeostasis:
as an iron chaperone for iron-sulfur cluster and heme synthesis, as a modulator of
protein partners in the Fe-S cluster assembly pathway and as an iron storage protein
within the mitochondria in a manner similar to cytosolic Ferritin but, only under
conditions of oxidative stress. Analysis of the activity and structure of two eukaryotic
frataxin orthologs (yeast and human) has been constrained by autodegradation and
aggregation. In contrast, the Drosophila frataxin homolog (Dfh) is stable making it a
perfect molecule for structure based functional characterization studies.
In this report, we describe the crystal structure and NMR assignments of apo
Dfh. In addition, using nuclear magnetic resonance (NMR) spectroscopy, we report
potential Fe(ll) binding residues on this protein. A previous graduate student (Dr. Swati
Rawat) who completed backbone chemical shift assignments for Dfh, initiated this work.
My contributions include sample preparation,

15

N HSQC data collection and processing,

and development of the crystallization for the apo-protein.
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Joseph Brunzelle (APS, Argonne National Laboratory) who crystallized Dfh and solved
the structure, Lindsey Thompson and John Rotondo who aided with protein purification
and Jefferson Plegaria (Pecoraro lab, University of Michigan) who aided with NMR data
processing. The text below is being prepared for publication in the journal Biochemistry.

4.2 Abstract:
Friedreich’s ataxia, the most prevalent hereditary ataxia is caused by a patient’s
inability to produce a viable form of the protein frataxin [1-3]. Frataxin is a nuclear
encoded protein transported to the mitochondrial matrix [1, 4] and believed to serve as
an iron chaperone/regulator of the Fe-S cluster (ISC) assembly pathway [5-9].
Frataxin’s role as an iron chaperone is controversial and atomic details of its interaction
with partner proteins are still unknown. While the in vitro studies on the human and
yeast orthologs have been plagued by the poor stability of the proteins, the Drosophila
homolog appears to resist autodegradation. Thus, a structural clarification of Dfh would
serve as a useful starting point for further studies into the molecular and atomic details
of frataxin’s function at a molecular level. With this goal in mind, we report the crystal
structure of Dfh, nearly complete NMR chemical shift assignments of the mature apoprotein and the identification of Dfh iron binding residues, obtained by NMR. The crystal
structure of the mature apo-Dfh suggests the protein is well folded with an alpha/beta
sandwich motif structure in agreement with the published structures for related orthologs
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[6, 10-12].

This work provides a starting point for further characterization of metal

binding and partner protein interaction sites in the stable fly system.

4.3 Introduction:
Friedreichʼs ataxia (FRDA), a cardio- and neurodegenerative disorder affecting 1
in 50,000, is caused by an inability to produce the mitochondrial protein “frataxin” [1].
Protein deficiency in FRDA patients is typically the result of an atypical GAA
trinucleotide intronic expansion in the frataxin gene that disrupts transcription, although
a subset of patients have frataxin single point mutations [3]. Phenotypes of the disorder
include Fe-S cluster (ISC) deficiency, as well as mitochondrial iron overload coupled to
cell death. This is a result of reactive oxygen species (ROS) induced oxidative stress
that occurs when the iron chemistry within the mitochondria is unregulated [13, 14].
Current treatment strategies for the disorder have suffered due to a lack of specific
knowledge regarding the exact role frataxin plays in regulating cellular iron homeostasis
[15]. Such functional knowledge at the molecular level would be extremely beneficial,
since it would provide an additional focal point to target new alternative drug treatment
strategies.
A large amount of work in the frataxin field has been performed using the yeast
and human model systems.

These studies have revealed valuable insight into the

biochemistry of the protein and its role in the molecular pathogenesis of FRDA [6, 1619]. However, FRDA research has suffered due to deficiencies in the proteins within
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these model systems. Instability of human frataxin with N-terminal autodegradation and
the high susceptibility for oxidation induced protein aggregation in the yeast ortholog
has plagued studies with both eukaryotic proteins [10, 20, 21]. Recently, our laboratory
fortuitously discovered that the frataxin homolog from Drosophila melanogaster (Dfh) is
much more stable than the other orthologs [8]. Thermal denaturation profiles showed
that Dfh melted at a temperature of 590C, compared to Yeast ortholog which melted at a
temperature of 440C [8]. Greater stability would make the fly system a perfect model for
structure/function characterization.
In addition to issues of protein stability, Dfh makes an excellent model system for
studying frataxin function since Dfh shares a high degree of sequence homology with
other frataxin orthologs (for example, 53% with the human protein) [22]. It also plays a
direct role in controlling cellular oxidative stress, with activity towards aconitase repair
and stability [23-26]. Under anaerobic conditions, Dfh exists as a stable iron-loaded
protein monomer which is arguably the functional form of the protein under normal
cellular conditions.

We have shown Dfh prevents reactive oxygen species-induced

oxidative damage to DNA in the presence of both Fe (II) and H2O2, so the protein has
additional functions beyond possible iron delivery. Finally, the fact that Dfh mediates
Fe(II) delivery to yeast Isu, promoting Fe-S cluster assembly in vitro in the process, has
implications for protein activity (and the potential for teasing out mechanistic details)
between species [8]. Given the direct correlation between frataxin’s function and ISC
biosynthesis, the fly model could therefore be exploited to provide real insight into Fe-
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cofactor bioassembly.
In this report we compare the structures of human, yeast and fly frataxin
orthologs, which are similar in fold and function, but exhibit subtle differences which
possibly form the basis for the extraordinary stability of Dfh. Finally, we identify Dfh
residues that may play a role in iron binding.

4.4 Materials & Methods:
4.4.1 Labeling, expression, and purification of Drosophila Frataxin
The Dfh construct was expressed in the E. coli BL21 (DE3) strain transformed with
a modified pET 101/D-TOPO vector DNA.

15

N-labeled and

13

C/15N doubly labeled

Drosophila frataxin, spanning amino acids 59–190, were obtained from bacteria grown
in M9 minimal medium with 15NH4Cl and 13C6 D-glucose as the sole nitrogen and carbon
sources, respectively. Unlabelled protein was overexpressed and isolated from bacteria
grown in Luria-Bertani broth. For unlabelled protein expression, cells were grown at
37°C followed by induction at OD600 of 0.6 with 1 mM IPTG for 6 hours. For labeled
protein expression, as cells grew at a slower pace in minimal media, growth was
continued overnight (16-18 hrs.) at 250C and then harvested. Cell pellets were stored at
-800C until use.
All protein isolation steps were carried out at 40C. Cell pellets re-suspended in
buffer containing 25 mM TRIS (pH: 8.0), 10mM EDTA, 5 mM β-Me (5 ml buffer/g cells)
in the presence of lysozyme (100 μg/μl), complete EDTA free protease inhibitor (1
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tablet/ 50 ml, Roche), DNAse (10 μg/ml) and MgCl2 (5 mM) were allowed to incubate for
~15mins.

Cells were lysed by three passes through a high-pressure homogenizer

(Emulsiflex C3, Avestin) and centrifuged at 21,000 rpm for one hour. The supernatant
was separated and filtered through a 0.2 μm filter and the crude soluble fraction was
subjected to two ammonium sulfate precipitation steps: salting in at 40% ammonium
sulfate followed by recovery of supernatant, and precipitation at 65% ammonium sulfate,
followed by resolubilization in lysis buffer. This partially purified preparation was then
dialyzed twice against a 1:200 volume dilution of Buffer A (25 mM Tris-HCl (pH: 8.0), 10
mM EDTA, 5 mM β -Me) for a minimum of 6 - 12 hours at 40C with one buffer change in
between to remove Ammonium Sulfate. Following dialysis, protein was filtered and
subjected to anion exchange chromatography using a Q-Sepharose column
(Pharmacia) equilibrated in Buffer A, and eluted using a salt gradient made with buffer B
(25 mM Tris-HCl (pH: 8.0), 10 mM EDTA, 1 M NaCl, 5 mM β-Me) up to a final
concentration of 1 M NaCl. Dfh eluted at a sodium chloride concentration of 500 mM.
Fractions containing Dfh were pooled and dialyzed against buffer A to remove NaCl.
The dialyzed protein was then made up to 1 M Ammonium Sulfate, filtered and loaded
onto a Phenyl-Sepharose column (Pharmacia) using Buffer A and a reverse 1 M
ammonium sulfate gradient in Buffer C (25 mM Tris-HCl (pH:8.0), 10 mM EDTA, 1M
Ammonium Sulfate, 5 mM β-Me). Dfh eluted at 800 mM ammonium sulfate. Fractions
containing Dfh were pooled and concentrated to 1 ml followed by a final purification step
by size-exclusion through a Sephacryl-75 column (GE) equilibrated with 20 mM HEPES
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(pH 7.5), 150 mM NaCl, 5 mM β-Me. Dfh eluted at a volume corresponding to a
monomer [8]. Isolated protein was concentrated and stored anaerobically in a glove box
(Coy Labs) at 40C or flash frozen in liquid nitrogen and stored at -800C. Typical yields
were 50mg/L of growth medium.

4.4.2 Crystallization and determination of apo-Dfh structure:
Purified unlabelled apo Dfh at ~2 mM concentration in 20 mM HEPES (pH: 7.5)
150 mM NaCl and 5 mM β-Me (Figure 4.1) was crystallized and the structure was
solved in collaboration with Dr. Joseph Brunzelle at the Advanced Photon Source,
Argonne National Laboratory.
Crystals of native Dfh were obtained by sitting drop vapor diffusion by mixing 1:1
ratio of 7.2 mg/mL protein with 0.1 M citric acid (pH 5.0) and 1.6 M ammonium sulfate
grown at 20ºC. Crystals were harvested, soaked in the mother liquor with 25% glycerol
and flash frozen in liquid nitrogen. Data were collected on the 21-ID-G beam line (LSCAT Sector-21) at the Advanced Photon Source (Argonne National Labs, Argonne IL).
A 1.405 Å data set was processed and scaled with autoPROC [27]. The structure was
solved by molecular replacement using PHENIX autoMR [28] with the atomic
coordinates of 1EKG, which was further built and refined manually using Coot [29] and
Phenix refine with TLS refinement [30], respectively. The final model was validated in
MolProbity [31]. Data collection and refinement statistics are provided in Table (4.1).
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Figure 4.1: SDS-PAGE gel showing Dfh purity. Unlabelled Dfh samples were
run on an SDS-PAGE gel after purification through a phenyl sepharose column.
The lane to the extreme right represents the protein marker and the lanes to the
left represent Dfh at varying concentrations. Protein obtained was >95% pure
and was used for crystallization.
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Table 4.1: Dfh crystallography data collection & refinement statistics.
Data collection
Wavelength (Å)

0.979

Space group

C2

Cell dimensions (Å)

a = 78.90, b = 38.51, c = 46.30, β = 123.45°

Resolution (Å)a

37-1.405 (1.41-1.405)

Observed reflections

74,124

Unique reflections

21,840

Rmerge (%)

a,b

Multiplicity

3.7 (32.8)

a

Completeness (%)

3.4 (2.1)
a

95.9 (75.6)

Refinement statistics
Resolution range (Å)

37–1.405

Rfactor (%)c

15.24

Rfree (%)

d

17.39

No. of protein atoms

1986

No. of non-protein atoms

10

No. of water molecules

140

Molprobity score

3.92

Ramachandran plot (%)

e

97.0/3.0/0.0

2

Average B factor (Å )
Protein

20.9

Non-Protein

46.2

Waters

31.4

Overall

21.7

RMSDs
Bond lengths (Å)

0.008

Bond angles (º)

1.191

a

The values in parentheses are for the highest resolution shell. b Rmerge = Σhkl Σi|I(hkl)i −
<I(hkl)>|/Σhkl Σi I(hkl)i, where I(hkl) is the intensity of reflection hkl, and <I(hkl)> is the average
intensity over all equivalent reflections. c Rfactor = Σ||Fo| − |Fc||/|Fo|, where |Fo| and |Fc| are the
observed and calculated structure factor amplitudes, respectively. d Rfree is the same as the
Rfactor but for a 5% subset of all reflections that were not used in the refinement. e
Core/allowed/disallowed.
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4.4.3 NMR Spectroscopy on Apo and Holo Dfh:
NMR spectra were acquired at 298 K on a Varian INOVA 720 MHz spectrometer
(National High Field Magnet Laboratory, Tallahassee FL) and on a Varian INOVA 600
MHz spectrometer (Wayne State University). The 720 MHz spectrometer was equipped
with a triple resonance gradient room temperature probe while the 600 MHz
spectrometer utilized a Varian triple resonance gradient cold probe. Frataxin samples
used in the backbone assignments were prepared at 1.2 mM concentration in NMR
buffer (20 mM HEPES, 150 mM NaCl, pH 7.5, 90% H2O /10% D2O).
assignments were made using the following experiments:

15

Backbone

N-HSQC, HNCO, HNCACB

and CBCA(CO)NH [32]. HNCACB spectra provide Cα and Cβ chemical shifts for the
amino acid of interest, as well as from the residue immediately N-terminal in the
protein’s sequence. CBCA (CO) NH spectra are used to verify chemical shifts of the Nterminal residue.

When combined, these data allow one to make sequential

assignments for the backbone of a protein. All spectra were analyzed according to
established lab protocols [6] using the processing programs NMRPipe [33] and nmrView
[34].

CSI analysis was performed using a program provided by nmrView using

backbone Cα, Carbonyl carbon and Nitrogen atoms only.

Secondary structure

prediction based on backbone atom chemical shift suggests that mature Dfh contains 2
alpha helices and 6 beta sheets in agreement with that of the crystal structure.
NMR amide chemical shift perturbation experiments were used to identify amino
acids affected by the presence of iron under solution conditions that stabilize the
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monomeric iron loaded Dfh protein.

15

N labeled apo Dfh protein at ~0.7 mM

concentration was prepared in the NMR buffer listed above: 20 mM HEPES (pH 7.5)
150 mM NaCl 5 mM β-mercaptoethanol, 90%H2O/ 10% D2O. Protein sample was preincubated in the glove box overnight at 40C followed by transfer to NMR tubes, which
were sealed with airtight septa.

Ferrous ammonium sulfate was also prepared

anaerobically within the glove box in the NMR buffer. For the holo Dfh sample, ferrous
ammonium sulfate at a concentration of 6mM was anaerobically titrated in 70 uL
volumes into the protein, to a final concentration of 1:1 Dfh to Fe(ll).

Protein

concentration after addition of Fe(ll) was ~0.63 mM. Spectra were collected on a Varian
INOVA 600 MHz spectrometer under conditions identical to backbone assignment
experiments outlined above. Samples were allowed to equilibrate to 25 0C within the
spectrometer prior to data collection.

Full

1

H/15N heteronuclear single quantum

coherence (HSQC) spectra were collected at each titration point using a 1H sweep width
of 7804 Hz (2048 points and 64 transients) and a

15

N sweep width of 2500 Hz (512

increments). Spectra were transformed as mentioned above using NMRPipe and peak
positions were calculated using SPARKY [35].

4.4.4 Assignments and data deposition
Residue assignments for the mature (59-190) Drosophila frataxin protein are
provided in the high-resolution

15

N-HSQC spectrum for the protein (Figure 4.4). Full

backbone assignment was achieved for 128 out of 133 residues. Five proline residues
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in the protein remain unassigned. For further reference, the residue sequence for fulllength Drosophila frataxin can be found at http://www.uniprot.org/uniprot/Q9W385.
Chemical shift assignments are deposited in the Biological Magnetic Resonance Bank
(http://www.bmrb.wisc.edu/) under the accession code BMRB- 17135.

4.5 Results:
4.5.1 Crystal structure of Drosophila Frataxin homolog (Dfh):
Crystallographic results indicate that Dfh has an overall fold that is highly similar
to the characterized ortholog structures [21]. The protein has an alpha-beta sandwich
motif comprising two α-helices that form one plane, with a succession of five β-strands
that are sandwiched between the α-helices forming the second plane of the molecule
[21]. A sixth β-strand intersects the two planes, thus forming the characteristic α-β
sandwich motif that is shared between the frataxin family of proteins (Figure 4.2 A). The
number of β-strands is variable between orthologs: yeast frataxin and the bacterial
homolog CyaY have six β-strands while a seventh strand has been reported only in the
human ortholog [21]. Sequence identity between proteins measured by clustal-ω
sequence alignment are 54% and 38% with the human and yeast proteins respectively
and 22% with the bacterial homolog CyaY (Figure 4.3). RMSD values between Dfh and
orthologs in regions of secondary structure are 1.13 Å and 1.44 Å respectively with the
human and yeast orthologs (measured using the ‘align’ tool on PyMoL [36]).

	
  

	
  

	
  

	
  

	
  

11
4	
  
Figure 4.2: The crystal structure of Drosophila frataxin homolog Dfh. (A) Ribbon structure and (B) Surface
electrostatic potential plots for Dfh at three different orientations around the vertical axis. (A) Labels for the different
secondary structural elements are marked adjacent to the corresponding helix or strand. (B) To the left is a surface
electrostatic potential plot for Dfh at an orientation that corresponds to the ribbon structure. Electrostatic surface
plots were calculated using the free PDB2PQR software* and modeled with the APBS plugin* for PyMoL using a
solvent radius of 1.4 Å and a contour value of 10 kT/e for both charged isoforms. Secondary structural landmarks
on the rotated structures are labeled for clarity. **[37, 38]
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Figure 4.3: Clustal-ω sequence alignment between Frataxin orthologs: D.
melanogaster (Dfh), H. sapien (HsFtx), S. cerevisiae (Yfh1WT) and E. coli (CyaY). Fully
conserved residues are indicated by an asterisk (*) under the residue.
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Structural instability associated with the human and yeast frataxins have been
attributed to their relatively unfolded N-terminus, prior to the helix-1, which leads to
protein autodegradation [21]. Mature human frataxin extends from residue 75-210 with
a total of 18 N-terminal residues and [10, 20], mature yeast frataxin spans residues 52174 [6] and, like the human ortholog has 18 N-terminal residues. On the other hand, the
structure of Dfh spans residues 65-190 and appears to have a relatively short unfolded
N-terminus comprising 5 residues only (Figure 4.2 A). In addition, frataxin’s C-terminal
residues past the helix-2 have been reported to be an additional determinant of protein
stability. Melting temperature studies on yeast frataxin correlated a longer C-terminus to
greater stability [21]. Human frataxin has a relatively long C-terminus of 16 residues,
while the yeast ortholog has only 3 residues terminal to helix-2. The C-terminus of Dfh
on the other hand comprises 18 residues, a part of which appears to be folded into a 310
helix and in addition, makes contact with helix-1 possibly providing added stability. A
combination of a relatively shorter N-terminus with a longer C-terminus, both of which
are attributes to greater stability are possibly factors that contribute to the resistance of
Dfh to degradation.
Figure 4.2 (B) shows the electrostatic surface plot of Dfh. The red region that
spans the first α-helix and first β-strand region represents the acidic patch that consists
of conserved, surface exposed acidic residues. This acidic patch is common to frataxin
proteins and has been identified to be crucial for frataxin’s iron binding ability and
interaction with partner proteins [21].
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4.5.2 Dfh backbone resonance assignments:
In order to exploit structural information regarding Dfh, we present the assignment
of the backbone atom chemical shifts, obtained by Nuclear Magnetic resonance (NMR)
spectroscopy, in this report. Dispersion of amide resonances in the

15

N HSQC spectra

of the 59-190 residues of fly frataxin construct (Figure 4.4) confirm the majority of
residues exist in a structured region. In order to avoid referencing errors, LACS (Linear
Analysis of Chemical Shift) analysis of the protein residues was performed.

LACS

analysis is used to detect the referencing errors. Linear regression plots between the
secondary shifts of the alpha and difference between the secondary shifts of the alpha
and beta carbons for residue ‘i’ of protein pass through the origin from two directions,
suggesting correct referencing. A total of 128 out of 133 residues of the mature Dfh
protein were assigned. The structure of Dfh was predicted using the Chemical Shift
Indices (CSI) program based on the backbone atom assignments. CSI is a program
that predicts protein’s secondary structure. CSI measures the deviation of the obtained
chemical shift value assigned to each backbone atom in the molecule of interest to
values from an averaged library for atoms in a random coil, helix and strand. The sign
and magnitude of these deviations can then be used to correlate the predicted
secondary structure type that the residue is found in, providing a rough estimate of the
probable secondary structure profile of the molecule from just the chemical shift
assignments.

Prediction of secondary structural elements for Dfh in solution using

chemical shift indices (CSI) analysis within the program nmrView [34]
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Figure 4.4. Assigned 15N HSQC spectrum of Dfh. Data was collected on the
National Magnet Laboratory’s Varian INOVA 720 MHz spectrometer at 298 K and at in
house INOVA 600 MHz
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suggests the protein secondary structural elements are highly conserved between
orthologs, and the structure most likely exists as an α/β sandwich motif family member
(Figure 4.5).

The predicted Dfh secondary structure lacks the N-terminal 310 helix

observed in the yeast frataxin structure [6] but it shows the presence of a beta strand
before the helix-1, suggesting the Dfh structure is little different than the human frataxin
N-terminal extension protein [11, 39]. Based on the predicted structural regions of the
protein using the highly reliable Ca, N and CO data, the structure of Dfh consists of
helices formed by the [residues 13-37 (H1) and 108-120 (H2)] and seven β-strands
covering residues 10-12 (S1), 46-48 (S2), 53-57 (S3), 72-74 (S4), 77-79 (S5), 88-93
(S6) and 96-100 (S7).
The CSI predicted structure of Dfh suggests that it consists of 27% beta strand and
36% helical content. Based on this predicted structure Isu binding residues on the Dfh
structure were determined. In case of yeast frataxin (Yfh1), the Isu binding residues
have been assigned. The corresponding residues of Dfh include Glu 32, Thr 35 (lie on
helix 1 region); Val 52, Leu 53, Thr 54, Val 55, Leu 57 (lie on beta sheet 1 surface); Gln
105, Gly 117 and Ser 119 (lie on loop and helix 2 surface).

Thus most of the

functionally important residues of frataxin lie on the same region on predicted protein as
in case of yeast frataxin.
The backbone atom chemical shift assignments of Dfh provides a control for
future experiments directed at monitoring structural changes on the protein coupled with
Fe (II) and partner protein binding. Using the predicted secondary structure model, we
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D	
  

Figure 4.5. Summary of proposed secondary structural elements for Dfh: based
on A) Cα, B) Cβ, C) Carbonyl carbon and D) N, in solution obtained from CSI analysis
using NMRView. Single letter residue designations are provided (top) with predicted
secondary structural elements displayed in red (helix), blue (strand) or grey (unfolded).
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Figure 4.6. Consensus secondary structure prediction. This structure is predicted
using the secondary structure prediction for Cα, N and Carbonyl carbon. Prediction is
made manually by using consensus where two of the three values points the same
prediction.
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found most of the corresponding residues in the yeast frataxin iron binding site (Ala 26,
Asp 29, Glu 36, Asn 37, Ala 47 and Tyr 48 - based on Dfh numbering) lie on the helix-1
and strand-2 portion of the molecule [5].

4.5.3 Mapping the putative iron binding residues on Dfh
NMR spectroscopy was used to identify frataxin amino acids that are influenced
by the presence of ferrous iron. A series of 1H-15N HSQC spectra were collected by
titrating anaerobic ferrous ammonium sulfate at a final ratio of 1:1 protein to Fe(ll). This
ratio was in keeping with previously reported Isothermal Titration Calorimetry results,
which showed that Dfh bound 1 atom of iron [8]. Both protein and Fe(ll) solutions were
prepared under strict anaerobic conditions to prevent any chances of oxidation. Data
was collected under conditions identical to those of the backbone assignment
experiments. Our control apo-Dfh spectrum was identical to that obtained observed in
Figure 4.4, enabling a direct comparison of the reproducible protein samples.

An

overlay of backbone amide chemical shifts in the apo and holo forms revealed 10
residues on Dfh underwent substantial chemical shift changes (Figure 4.7). Residues
that are shifted include D25, A26, E36, N37, D45, T54, V55, N56, H61 and E114. In
addition, residues that disappeared upon addition of iron include Y30, E33, S52, F88,
G100, V103, and Y105, the disappearance is a possible indication of residues being in
close proximity to the paramagnetic metal. The positions on the apofrataxin structure
that

	
  

are

affected

by

the

presence

	
  

	
  

of

iron

are

shown

in

(Figure

4.8).
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Figure 4.7. Overlay of 2D 1H-15N HSQC spectra for Dfh. (Zoomed in for clarity). Apo
protein peaks are shown in red and holo protein peaks in blue. Spectra were collected
on a Varian Inova 600 MHz spectrometer at 25 0C in 20 mM HEPES (pH: 7.5) 150 mM
NaCl and 5 mM β-mercaptoethanol. Peaks that showed substantial chemical shift
perturbations were identified by comparison to the map of assigned Dfh backbone
resonances (Figure 4.4).
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Figure 4.8 Perturbed residues upon Fe (ll) titration into Dfh. Determined by 2D 1H15
N HSQC NMR spectroscopy and modeled on PyMoL [36]. (A) Orientation 1 showing
the helix-1and strand-1 acidic patch & (B) Orientation 2 showing the plane formed by
helices & strands. Residues that showed a perturbation upon iron addition (colored
blue) include D25, A26, E36 and E37 on helix-1; D45 on strand-1; T54, V55 and N56 on
strand-2; H61 on the strand 2, 3 loop and E114 on helix-2. Residues that disappeared
upon iron addition (colored red) include Y30, F31, E33 located on the helix-1 region;
G43 on the helix, strand-1 loop; V46 and Y48 on strand-1; S52 on the strand 4, 5 loop
and Q113 on helix-2.
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4.6: Discussion:
Similarity between frataxin orthologs and determinants of stability:
All the characterized frataxins so far (Human, yeast, bacterial and fly) share a
common structural fold comprising a characteristic α-β sandwich motif with a
characteristic acidic patch in the region spanning helix-1 and strand-1 [21]. This region
also contributes to the characteristic acidic pI of the protein: Dfh has a theoretical pI of
4.65 which matches those of the human (4.98), yeast (4.34) and E. coli (4.24) proteins
[6]. Surface exposed and charged residues in this acidic patch have been shown to be
responsible for the iron binding properties of the Frataxin family [21].
Although the structures are similar with a well folded globular C-terminus, the
human and yeast proteins have been reported to be inherently unstable due to a high
susceptibility to autodegradation.

One of the main reasons that contribute to

autodegradation is the relatively long and unfolded N-terminal region, prior to helix-1.
Both the yeast and human proteins have an 18 residue long N-terminus in the mature
form [21] . The function of this unfolded N-terminus is unclear. In the human ortholog, it
has been reported to function in binding Isu and also in binding iron [40, 41]. For Dfh,
the presence of a mitochondrial targeting sequence has been reported [22] however; in
vivo details of processing intermediates in the formation of mature Dfh are not yet
available. Our crystal structure spanning residues 65-190 of the open reading frame
shows the presence of a relatively shorter N-terminus of 5 residues. An additional
structural feature that possibly contributes to the stability of Dfh is its long C-terminus,
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which extends past helix-2, comprising 18 residues in length. A longer C-terminus has
been associated with a higher melting temperature and stability. Thermal denaturation
experiments have shown that Dfh melts at 590C, while the human and yeast orthologs
melt at 600C and 440C respectively. Human frataxin has a 16 residue spanning Cterminus while yeast has only three residues. However, the increased susceptibility of
human frataxin’s N-terminus to autodegradation possibly contributes to its overall
instability [21].

Iron binding properties of Drosophila Frataxin:
Data was collected at a stoichiometry of 1:1 protein to iron in keeping with
previous results from isothermal titration calorimetry [8]. Even at a 1:1 Fe:protein
concentration, substantial chemical shift perturbations were observed, along with peak
disappearance suggestive of residues in the vicinity of paramagnetic metal (see Figures
4.7, 4.8). Iron predominantly binds charged oxygen or nitrogen based amino acids, and
to a lesser extent, thiols [6]. Most of these residues are located in the conserved helix-1,
strand-1 acidic patch and are predominantly oxygen/nitrogen based, which fits well with
our published XAS data on Dfh which shows Fe(ll) bound in an octahedral complex
formed by oxygen/ nitrogen based ligands [8]. The resonance shifted residues are a
good indicator of iron proximity, and on helix-1 the charged residues include Y30 and
E33 were line broadened. Both these residues are solvent exposed indicating a possible
role in iron binding. An additional F31 was also line broadened possibly due to its

	
  

	
  

	
  

	
  

	
  

127	
  

proximity to the above residues. On strand-1, Y46 was line broadened, however not
solvent exposed. An additional charged residue that was line broadened is Q113 on
helix-2. Residues that were perturbed appear to flank the sides of the line broadened
residues. The occurrence of perturbed residues in clusters on helix-1 and on strand-1
indicates the possibility of greater than one iron-binding site, as observed in the case of
yeast frataxin which binds two iron atoms at sites located on helix-1 and strands-1& 2
[5]. Human frataxin has been shown to bind up to 6 atoms of iron [42]. In addition, a
cluster of residues in the region around the loops of strands-2 &3; strands-4 & 5 and the
helix-2 could indicate a molecular rearrangement in structure as a result of metal
binding or an additional metal binding site of a different functional significance.
Experiments are currently underway to collect holo Dfh data at sub-stoichiometric and at
higher concentrations to obtain more accurate information on residues that are shifted
and stoichiometry of Fe (ll) binding. A final confirmation of the possible iron binding
sites would be site directed mutagenesis followed by tests for iron binding.

Biological Significance:
This study provides a complete description of the crystal structure of the
Drosophila frataxin homolog (Dfh) from D. melanogaster. In addition we completed
backbone resonance assignments for Dfh residues using NMR.

These backbone

assignments were used to determine putative residues involved in Fe (ll) binding. Our
studies show that Dfh is a well-folded protein with a fold similar to those of characterized
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orthologs in the Frataxin family. The monomeric form of the protein was used in all
experiments and was shown to be able to bind iron, at sites that are predominantly
located in the helix-1, strand-1 region just as in the case of the human and yeast
frataxins indicating an iron chaperone role for Dfh is possible [21]. Though similar in its
structure and function to related orthologs, Dfh appears to be far more stable against
autodegradation.

Experiments are currently underway to map binding interfaces

between Dfh & DIsu and additional binding partners.
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CHAPTER 5
SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS

5.1 Significance of Iron in health:
Iron is the most common transition metal in the earth’s crust and the most
abundantly used transition metal among living organisms [1]. Its biological significance
is largely attributed to its ability to undergo reversible oxidation-reduction chemistry that
enables its participation in electron transfer reactions [2]. However, as a cofactor
associated with proteins, its functions are not limited to electron transfer alone, but also
include oxygen binding (hemoglobin) [3], catalysis (aconitase) [4], free-radical
generation (SAM enzymes) [5] among many more. Its versatility in function allows iron
to participate in various processes that sustain life such as oxygen transport, oxidative
metabolism, xenobiotic metabolism, ribonucleotide reduction during DNA synthesis, and
for DNA repair [1, 2, 6].

Considering its biological significance, understanding its

metabolism is crucial to maintaining a healthy population.
As essential as it is for survival, iron in excess can be detrimental. In the reaction
described as ‘Fenton Chemistry’, ferrous iron participates in the generation of deadly
hydroxyl radicals that can cause widespread damage to DNA, protein, membrane lipids
and cellular constituents leading to cell death [7]. Iron-induced free radical damage has
been implicated in the pathology of diseases of iron overload such as Friedreich’s
Ataxia, a genetic disorder characterized by an accumulation of iron in actively
metabolizing tissues ultimately leading to cardio- and neuro- degeneration and cell

	
  

	
  

	
  

	
  

	
  

death [8, 9].

135	
  

In addition, neurodegenerative disorders such as Alzheimer’s and

Parkinson’s disease are also associated with pathology caused by iron accumulation
[10, 11]. At the other end of the spectrum, a deficiency of iron is associated with anemia
[12] and has been reported to have deleterious effects on neurotransmission,
myelination, and dopamine receptor and transporter functions [2]. Anemia is the most
prevalent nutritional disorder worldwide, affecting about 30% of the world’s population
according to the NIH.

In addition, we do not fully understand the role of iron in

neurodegenerative disorders [13]. Therefore, iron metabolism has become an important
research directive at national funding agencies.

5.2 Summary & Future Directions
Cellular iron metallochaperones are an important aspect of metal homeostasis.
They are often small diffusible molecules that bind metal preventing any incidence of
free radical generation [14].

The first chapter of my thesis is a review article that

outlines the roles of two potential cellular iron chaperones, the mitochondrial iron
chaperone Frataxin and the cytosolic PCBP family of proteins. Frataxin plays a key role
in iron homeostasis, evident from pathogenesis associated with the debilitating disease
Friedreich’s Ataxia, described above, caused by an inability to synthesize this single
protein. Frataxin has been shown by numerous groups to be a part of the iron-sulfur
cluster (ISC) multicomplex, where it functions in the capacity of a potential iron provider
and an allosteric modulator of both the cysteine desulfurase and scaffold protein Isu [15-
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Other roles have been described, including an ability to oligomerize in the

presence of oxygen and a ferroxidase ability that enables storage of ferric iron in a
manner similar to ferritin [2, 7]. The role of frataxin needs to be clarified to assist in the
development of improved research strategies for treating FRDA.
The first chapter also outlines the role of the cytosolic PCBP family and describes
its role in chaperoning iron to Ferritin for storage. The iron binding and thermodynamic
properties of PCPB have been established [18] but a structural characterization of the
protein and residues involved in iron binding are still lacking. Further clarification of the
activity of the PCBP protein family will provide additional insight into cellular iron
distribution strategies.
The second and third chapters of my thesis are focused on understanding the
initial events of iron loading onto the iron-sulfur cluster scaffold protein. The second
chapter describes the Fe(ll) binding properties of ISU using four orthologs (human, fly,
yeast and from the thermophile Thermatoga). By ITC, the ISU proteins were found to
bind Fe(ll) with a nanomolar to micromolar affinity. Using XAS, the Stemmler laboratory
characterized the ISU-Fe(ll) bound complex in these orthologs and found that ISU
appears to bind iron in a 6 coordinate oxygen/nitrogen ligand environment.

The

absence of any thiol ligation to metal indicates iron loading onto ISU occurs at a site
distinct from its cysteine rich active site. These findings were confirmed by Mössbauer
spectroscopy. This would suggest that if Frataxin interacts with ISU to deliver iron, it
may interact with the protein at this distinct metal-loading site.
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The third chapter of my thesis builds off of the results of chapter 2 and is directed
at elucidating the initial Fe(II) loading site on ISU, using the yeast model system. The
C-terminal helix of ISU has a high percentage of charged residues (approx. 50% based
on the modeled structure of YIsu1) and appears to undergo an increase in order of fold
upon substrate binding, similar to the transition demonstrated by the crystal structure of
ISU in A. aeolicus [19].

Based on the crystal structure of E. coli IscU-IscS and

predictive modeling of the Frataxin ortholog CyaY docking to the complex [20], the Cterminus of IscU appears to be in a perfect orientation to bind CyaY and its charged
surface would provide a complementary surface to Frataxin’s charged surface that has
been implicated in iron binding and Isu interaction in yeast. Yeast Isu1 residues E144A,
and D145A and a double mutant E144A, D145A located on the protein’s C-terminal αhelix, were mutated by site directed mutagenesis. Among these, using competition
assays, E144A, D145A and double mutants confirmed a drop in affinity for Fe(ll) at one
site, while the affinity at the other site was only marginally decreased. Binding of mutant
proteins E144A and D145A to holo-Yfh1, measured by ITC followed an endothermic
pattern of binding and was accompanied by a rise in enthalpy indicating an enthalpically
unfavorable process. Binding of holo-Yfh1 to WT YIsu1, on the other hand was an
enthalpically favorable process. This indicates that a mutation of the D145A residue
perturbs the interaction between frataxin and YIsu1. In addition, thermal denaturation
experiments using DSC performed on holo WT YIsu1 was associated with a shift to
higher temperature indicating a stabilizing change upon Fe(ll) binding.
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however, the holo D145A mutant shifted to a lower temperature indicating
destabilization upon iron binding. Thermodynamics associated with denaturation of the
holo forms of the mutant proteins were associated with a rise in enthalpy and entropy,
while holo YIsu1 showed no significant change in associated thermodynamics
compared to the apo form.

This possibly indicates that the stabilizing change in

structure in WT YIsu1 balances changes in energetics upon binding Fe(ll). The ability of
YIsu1 WT and the D145A mutant to synthesize Fe-S clusters was also tested by an FeS assembly assay using Near UV circular dichroism in the presence of either Fe(ll) or
holo-Yfh1. WT YIsu1 showed a clear rise in activity in the presence of holo Frataxin
compared Fe(ll) alone. On the other hand, the D145A mutant showed a higher activity
in the presence of Fe(ll) alone via a reaction that was slower than that in the presence of
holo Yfh1, which was a reaction that appeared to reach saturation quickly. This is
consistent with the ITC results obtained with holo-Yfh1, which showed a weak binding of
holo-Yfh1WT with D145A and thus, a weaker interaction.

In addition the mutant

reaction with Yfh1WT possibly saturated faster due to a loss of an iron-binding site. As
iron binding is clearly facilitated by holo-Yfh1WT, in its absence, the mutant protein
would take longer to bind iron and saturate the active site. These results collectively
indicate that the c-terminal charged residue D145A on Isu could be a possible ligand for
holo frataxin interaction.
An additional study that could further confirm that residues on YIsu1’s C-terminus
are involved in frataxin binding is currently underway in the Stemmler laboratory, in
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collaboration with Dr. Andrew Dancis (University of Pennsylvania). Three constructs
have been synthesized with a cleavable thrombin-His tag and with 10, 17 and 22 Cterminal residues deleted. Experiments are currently underway to determine which of
these constructs show perturbations with frataxin binding. Figure 5.1 shows an amino
acid sequence alignment of these constructs after DNA isolation and sequencing.
Obtaining a crystal structure of holo Yfh1WT and WT YIsu1 would be the final
confirmation of the initial binding site. Attempts, however, at crystallization have been
plagued by poor stability of the yeast proteins and the redox activity of iron. As an
alternative method, the Drosophila proteins are also being tested for crystallization.
Since Drosophila frataxin appears easily crystallizable, and, as we now have its crystal
structure as a starting point, there is some indication that we may have the same
success with DIsu.
The final chapter of my thesis is a structural characterization of the Drosophila
frataxin homolog Dfh.

Dfh was crystallized and the structure of the protein was

determined by Dr. Joseph Brunzelle (APS, Argonne National Laboratories). Like its
yeast and human homologs, Dfh is well-folded with an α-β sandwich motif comprising
two α-helices and six β-strands sandwiched between the two helices [21, 22]. The Dfh
protein does not have a long unstructured N-terminal region like that seen in the yeast
and human proteins [7, 23], and it has a considerably longer C-terminal tail; two factors
that could contribute to its extraordinary stability. Electrostatic potential surface plots
show the presence of the conserved acidic patch at the α1-β1region on Dfh. This acidic
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Figure 5.1: Multiple sequence alignments of YIsu1 c-terminal truncation
mutants after DNA isolation and sequencing: YIsu1 Δ10, Δ17 and Δ22 aligned
with the YIsu1WT construct.
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patch has been described to be important for the function of the frataxin proteins [7].
15

N HSQC experiments performed on Dfh in the presence of iron show that the majority

of the perturbed residues lie on the α helix-1 and β-strands 1 & 2 region; this is in the
region of the conserved acidic patch indicating an Fe chaperone role for Dfh. Additional
studies directed at characterizing the Dfh iron binding site involve collecting 1H-15N
HSQC data upon titrating Fe(ll) into the protein at sub-stoichiometric and excess Fe to
get insight into both residues that are perturbed and line broadened which would give an
accurate estimate of the Fe binding site.

It will also provide some insight into

stoichiometry, as upon excess Fe(ll) titration, protein aggregation alters the peak
dispersion pattern. As a future direction, mutation of these perturbed residues would be
a good confirmation of their role in iron binding.
Determining the structure of the multiprotein complex would provide real insight
into how the complex functions. This is a major goal of our lab, through collaboration
with Dr. Amy Rosenzweig’s laboratory (Northwestern University). As the Dfh protein
has been found to be much more stable than its yeast and human counterparts, it would
serve

as

a

great

starting

point

to

attempt

to

crystallize

the

cysteine

desulfurase/Isd11/Isu/Frataxin (SDUF) proteins in the Drosophila system considering
the poor stability of the yeast proteins.
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5.3 Conclusion
One of the main goals of the Stemmler laboratory is to provide insight into role of
the mitochondrial iron binding protein Frataxin in cellular iron homeostasis. There is
much speculation over the role of Frataxin as a possible iron chaperone for iron-sulfur
cluster assembly. Our work, along with others, have shown that Frataxin binds iron,
and binds Isu, in a stable complex that appears to enhance iron-sulfur cluster assembly
on Isu, a behavior consistent with that of a metal chaperone [15, 24, 25]. The bulk of
my thesis was to characterize the initial Fe delivery site by Frataxin/Fe(II) acceptance
site on Isu. Residues on the C-terminus of Isu, upon mutagenesis to alanine, show a
perturbation upon iron and holo-Yfh1WT binding. A crystal structure would confirm
these being the ligands of the 6-coordinate Isu-Fe (ll) complex determined by XAS. In
addition, this would reveal the residues that form the protein-protein interface. This
would serve as a good starting point for drug design of molecules that can mimic
Frataxin’s activity as there is yet no cure for Friedreich’s Ataxia (FRDA) [8]. On the
same note, the crystal structure of Dfh along with its extraordinary stability would serve
as a good starting point for crystallization of holo Dfh-DIsu and holo SDUF.
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Iron-induced free radical damage has been implicated in the pathology of diseases of
iron overload such as Friedreich’s Ataxia, a genetic disorder characterized by an
accumulation of iron in actively metabolizing tissues ultimately leading to cardio- and
neuro- degeneration and cell death.

It is caused by an inability to synthesize the

mitochondrial protein, frataxin. Frataxin has been shown by numerous groups to be a
part of the iron-sulfur cluster (ISC) multicomplex, where it functions in the capacity of a
potential iron provider and an allosteric modulator of both the cysteine desulfurase and
scaffold protein ISU.

My research has been focused on studying the interaction

between frataxin and ISU, particularly the mechanism of iron binding/ iron acceptance
by ISU from frataxin. Using XAS, the Stemmler laboratory characterized the ISU-Fe(ll)
bound complex in four orthologs and found that ISU appears to bind iron in a 6
coordinate oxygen/nitrogen ligand environment. The absence of any thiol ligation to
metal indicates iron loading onto ISU occurs at a site distinct from its cysteine rich active
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site. Using site directed mutagenesis, followed by biochemical and biophysical analysis
of the mutant proteins in the yeast system, we demonstrate that charged residues
E144A and D145A possibly form the interface between iron loaded frataxin and ISU and
are involved in initial iron acceptance by ISU.

In this thesis, we also describe the crystal structure of Frataxin in D.
melanogaster (Dfh). Dfh is well-folded with an α-β sandwich motif comprising two αhelices and six β-strands sandwiched between the two helices like its yeast and human
homologs. The Dfh protein does not have a long unstructured N-terminal region like that
seen in the yeast and human proteins and it has a considerably longer C-terminal tail;
two factors that could contribute to its extraordinary stability.

15

N HSQC experiments

performed on Dfh in the presence of iron show that the majority of the perturbed
residues lie on the α helix-1 and β-strands 1 & 2 region; this is in the region of the
conserved acidic patch shared by frataxin proteins indicating an iron binding/ chaperone
role for Dfh. As the Dfh protein has been found to be much more stable than its yeast
and human counterparts, it would serve as a great starting point to attempt to crystallize
the cysteine desulfurase/Isd11/Isu/frataxin (SDUF) proteins in the Drosophila system
considering the poor stability of the yeast proteins.
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